ANNEX 1A
Index No | Chemical name | Notes related to substances | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes related to preparations
001-002-00-4 | aluminium lithium hydride | | 240-877-9 | 16853-85-3 | F; R15 C; R35 | F; C R: 15-35 S: (1/2-)7/8-26-36/37/39-43-45 | |
005-006-00-7 | dibutyltin hydrogen borate | E | 401-040-5 | 75113-37-0 | Muta. Cat. 3; R68 Repr. Cat. 2; R60-61 T; R48/25 Xn; R21/22 Xi; R41 R43 N; R50-53 | T; N R: 60-61-21/22-41-43-48/25-68-50/53 S: 53-45-60-61 | |
006-007-00-5 | salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex | A | — | — | T+; R26/27/28 R32 N; R50-53 | T+; N R: 26/27/28-32-50/53 S: (1/2-)7-28-29-45-60-61 | |
006-015-00-9 | diuron (ISO); 3-(3,4-dichlorophenyl)-1,1-dimethylurea | | 206-354-4 | 330-54-1 | Carc. Cat. 3; R40 Xn; R22-48/22 N; R50-53 | Xn; N R: 22-40-48/22-50/53 S: (2-)13-36/37-46-60-61 | C ≥ 25 %: Xn, N; R22-40-48/22-50/53 10 % ≤ C < 25 %: Xn, N; R40-48/22-50/53 2,5 % ≤ C < 10 %: Xn, N; R40-50/53 1 % ≤ C < 2,5 %: Xn, N; R40-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
006-076-00-1 | mancozeb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt | | — | 8018-01-7 | Repr. Cat. 3; R63 R43 N; R50 | Xn; N R: 43-63-50 S: (2-)36/37-46-61 | C ≥ 5 %: Xn, N; R43-63-50 2,5 ≤ C < 5 %: Xi, N; R43-50 1 % ≤ C < 2,5 %: Xi; R43 |
006-077-00-7 | maneb (ISO); manganese ethylenebis(dithiocarbamate) (polymeric) | | 235-654-8 | 12427-38-2 | Repr. Cat. 3; R63 Xn; R20 Xi; R36 R43 N; R50-53 | Xn; N R: 20-36-43-63-50/53 S: (2-)36/37-46-60-61 | C ≥ 25 %: Xn, N; R20-36-43-63-50/53 20 % ≤ C < 25 %: Xn, N; R36-43-63-50/53 5 % ≤ C < 20 %: Xn, N; R43-63-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
006-084-00-5 | carbosulfan (ISO); 2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate | | 259-565-9 | 55285-14-8 | T+; R26 T; R25 R43 N; R50-53 | T+; N R: 25-26-43-50/53 S: (1/2-)28-36/37-38-45-63-60-61 | |
006-088-00-7 | benfuracarb (ISO); ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninate | | — | 82560-54-1 | Repr. Cat. 3; R62 T; R23 Xn; R22 N; R50-53 | T; N R: 22-23-62-50/53 S: (1/2-)36/37-45-60-61 | |
007-002-00-0 | nitrogen dioxide; [1] dinitrogen tetraoxide [2] | | 233-272-6 [1] 234-126-4 [2] | 10102-44-0 [1] 10544-72-6 [2] | O; R8 T+; R26 C; R34 | O; T+ R: 8-26-34 S: (1/2-)9-26-28-36/37/39-45 | C ≥ 10 %: T+; R26-34 5 % ≤ C < 10 %: T; R23-34 1 % ≤ C < 5 %: T; R23-36/37/38 0,5 % ≤ C < 1 %: Xn; R20-36/37/38 0,1 % ≤ C < 0,5 %: Xn; R20 | 5
015-041-00-X | malathion (ISO); 1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate; [containing ≤ 0,03 % isomalathion] | | 204-497-7 | 121-75-5 | Xn; R22 R43 N; R50-53 | Xn; N R: 22-43-50/53 S: (2-)24-37-46-60-61 | C ≥ 25 %: Xn, N; R22-43-50/53 1 % ≤ C < 25 %: Xi, N; R43-50/53 0,025 % ≤ C < 1 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 |
015-100-00-X | phoxim (ISO); α-(diethoxyphosphinothioylimino) phenylacetonitrile | | 238-887-3 | 14816-18-3 | Repr. Cat. 3; R62 Xn; R22 R43 N; R50-53 | Xn; N R: 22-43-62-50/53 S: (2-)36/37-46-60-61 | C ≥ 25 %: Xn, N; R22-43-62-50/53 5 % ≤ C < 25 %: Xn, N; R43-62-50/53 1 % ≤ C < 5 %: Xi, N; R43-50/53 0,025 % ≤ C < 1 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 |
015-102-00-0 | tris(2-chloroethyl)phosphate | E | 204-118-5 | 115-96-8 | Carc. Cat. 3; R40 Repr. Cat. 2; R60 Xn; R22 N; R51-53 | T; N R: 60-22-40-51/53 S: 53-45-61 | |
015-155-00-X | glufosinate ammonium (ISO); ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate | E | 278-636-5 | 77182-82-2 | Repr. Cat. 2; R60 Repr. Cat. 3; R63 Xn; R20/21/22-48/20/22 | T R: 60-20/21/22-48/20/22-63 S: 53-45 | |
016-009-00-8 | disodium sulfide; sodium sulfide | | 215-211-5 | 1313-82-2 | T; R24 Xn; R22 C; R34 R31 N; R50 | T; C; N R: 22-24-31-34-50 S: (1/2-)26-36/37/39-45-61 | |
017-009-00-0 | ammonium perchlorate; [containing ≥ 80 % of 0-30 μm particles] | T | 232-235-1 | 7790-98-9 | E; R3 O; R9 | E R: 3-9 S: (2-)14-16-36/37 | |
024-004-00-7 | sodium dichromate | E | 234-190-3 | 10588-01-9 | O; R8 Carc. Cat. 2; R45 Muta. Cat. 2; R46 Repr. Cat. 2; R60-61 T+; R26 T; R25-48/23 Xn; R21 C; R34 R42/43 N; R50-53 | O; T+; N R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53 S: 53-45-60-61 | C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/53 10 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/53 7 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/53 5 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/53 3 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/53 2,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/53 1 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/53 0,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/53 0,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/53 0,2 % ≤ C < 0,25 %: T; R45-46-20-42/43 0,1 % ≤ C < 0,2 %: T; R45-46-20 | 3
027-002-00-4 | cobalt oxide | | 215-154-6 | 1307-96-6 | Xn; R22 R43 N; R50-53 | Xn; N R: 22-43-50/53 S: (2-)24-37-60-61 | C ≥ 25 %: Xn, N; R22-43-50/53 2,5 % ≤ C < 25 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
027-003-00-X | cobalt sulfide | | 215-273-3 | 1317-42-6 | R43 N; R50-53 | Xi; N R: 43-50/53 S: (2-)24-37-60-61 | C ≥ 2,5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
028-003-00-2 | nickel monoxide; [1] nickel oxide; [2] bunsenite [3] | E | 215-215-7 [1] 234-323-5 [2] - [3] | 1313-99-1 [1] 11099-02-8 [2] 34492-97-2 [3] | Carc. Cat. 1; R49 T; R48/23 R43 R53 | T R: 49-43-48/23-53 S: 53-45-61 | |
028-004-00-8 | nickel dioxide | E | 234-823-3 | 12035-36-8 | Carc. Cat. 1; R49 T; R48/23 R43 R53 | T R: 49-43-48/23-53 S: 53-45-61 | |
028-005-00-3 | dinickel trioxide | E | 215-217-8 | 1314-06-3 | Carc. Cat. 1; R49 T; R48/23 R43 R53 | T R: 49-43-48/23-53 S: 53-45-61 | |
028-006-00-9 | nickel (II) sulfide; [1] nickel sulfide; [2] millerite [3] | E | 240-841-2 [1] 234-349-7 [2] - [3] | 16812-54-7 [1] 11113-75-0 [2] 1314-04-1 [3] | Carc. Cat. 1; R49 Muta. Cat. 3; R68 T; R48/23 R43 N; R50-53 | T; N R: 49-43-48/23-68-50/53 S: 53-45-60-61 | |
028-007-00-4 | trinickel disulfide; nickel subsulfide; [1] heazlewoodite [2] | E | 234-829-6 [1] - [2] | 12035-72-2 [1] 12035-71-1 [2] | Carc. Cat. 1; R49 Muta. Cat. 3; R68 T; R48/23 R43 N; R50-53 | T; N R: 49-43-48/23-68-50/53 S: 53-45-60-61 | |
028-008-00-X | nickel dihydroxide; [1] nickel hydroxide [2] | E | 235-008-5 [1] 234-348-1 [2] | 12054-48-7 [1] 11113-74-9 [2] | Carc. Cat. 1; R49 Repr. Cat. 2; R61 Muta. Cat. 3; R68 T; R48/23 Xn; R20/22 Xi; R38 R42/43 N; R50-53 | T; N R: 49-61-20/22-38-42/43-48/23-68-50/53 S: 53-45-60-61 | |
029-013-00-X | trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II) | | 407-580-8 | 130201-51-3 | Xi; R41 | Xi R: 41 S: (2-)26-39 | |
033-005-00-1 | arsenic acid and its salts with the exception of those specified elsewhere in this Annex | AE | — | — | Carc. Cat. 1; R45 T; R23/25 N; R50-53 | T; N R: 45-23/25-50/53 S: 53-45-60-61 | |
034-002-00-8 | selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex | A | — | — | T; R23/25 R33 N; R50-53 | T; N R: 23/25-33-50/53 S: (1/2-)20/21-28-45-60-61 | |
047-001-00-2 | silver nitrate | | 231-853-9 | 7761-88-8 | O; R8 C; R34 N; R50-53 | O; C; N R: 8-34-50/53 S: (1/2-)26-36/37/39-45-60-61 | |
050-002-00-0 | cyhexatin (ISO); hydroxytricyclohexylstannane; tri(cyclohexyl)tin hydroxide | | 236-049-1 | 13121-70-5 | Xn; R20/21/22 N; R50-53 | Xn; N R: 20/21/22-50/53 S: (2-)13-60-61 | C ≥ 25 %: Xn, N; R20/21/22-50/53 0,025 % ≤ C < 25 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 |
050-003-00-6 | fentin acetate (ISO); triphenyltin acetate | | 212-984-0 | 900-95-8 | Carc. Cat. 3; R40 Repr. Cat. 3; R63 T+; R26 T; R24/25-48/23 Xi; R37/38-41 N; R50-53 | T+; N R: 24/25-26-37/38-40-41-48/23-63-50/53 S: (1/2-)26-28-36/37/39-45-60-61 | C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53 20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53 10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53 7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53 5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53 3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53 2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53 1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53 0,25 % ≤ C < 1 %: Xn, N; R20-51/53 0,1 % ≤ C < 0,25 %: Xn; R20-52/53 0,025 % ≤ C < 0,1 %: R52/53 |
050-004-00-1 | fentin hydroxide (ISO); triphenyltin hydroxide | | 200-990-6 | 76-87-9 | Carc. Cat. 3; R40 Repr. Cat. 3; R63 T+; R26 T; R24/25-48/23 Xi; R37/38-41 N; R50-53 | T+; N R: 24/25-26-37/38-40-41-48/23-63-50/53 S: (1/2-)26-28-36/37/39-45-60-61 | C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53 20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53 10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53 7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53 5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53 3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53 2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53 1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53 0,25 % ≤ C < 1 %: Xn, N; R20-51/53 0,1 % ≤ C < 0,25 %: Xn; R20-52/53 0,025 % ≤ C < 0,1 %: R52/53 |
050-008-00-3 | tributyltin compounds, with the exception of those specified elsewhere in this Annex | A | — | — | T; R25-48/23/25 Xn; R21 Xi; R36/38 N; R50-53 | T; N R: 21-25-36/38-48/23/25-50/53 S: (1/2-)36/37/39-45-60-61 | C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/53 1 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/53 0,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/53 0,025 % C < 0,25 %: R52/53 | 1
050-011-00-X | triphenyltin compounds, with the exception of those specified elsewhere in this Annex | A | — | — | T; R23/24/25 N; R50-53 | T; N R: 23/24/25-50/53 S: (1/2-)26-27-28-45-60-61 | C ≥ 1 %: T, N; R23/24/25-50/53 0,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 % ≤ C < 0,025 %: R52/53 | 1
050-018-00-8 | tin(II) methanesulphonate | | 401-640-7 | 53408-94-9 | C; R34 Xn; R22 R43 N; R51-53 | C; N R: 22-34-43-51/53 S: (1/2-)22-26-36/37/39-45-61 | |
053-003-00-4 | iodoxybenzene | | — | 696-33-3 | E; R2 | E R: 2 S: (2-)35 | |
053-004-00-X | calcium iodoxybenzoate | C | — | — | E; R2 | E R: 2 S: (2-)35 | |
080-001-00-0 | mercury | E | 231-106-7 | 7439-97-6 | Repr. Cat. 2; R61 T+; R26 T; R48/23 N; R50-53 | T+; N R: 61-26-48/23-50/53 S: 53-45-60-61 | |
080-010-00-X | mercury dichloride; mercuric chloride | | 231-299-8 | 7487-94-7 | Muta. Cat. 3; R68 Repr. Cat. 3; R62 T+; R28 T; R48/24/25 C; R34 N; R50-53 | T+; N R: 28-34-48/24/25-62-68-50/53 S: (1/2-)26-36/37/39-45-60-61 | |
092-002-00-3 | uranium compounds with the exception of those specified elsewhere in this Annex | A | — | — | T+; R26/28 R33 N; R51-53 | T+; N R: 26/28-33-51/53 S: (1/2-)20/21-45-61 | |
601-065-00-3 | A mixture of: (1′α,3′α,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane); (1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane) | | 416-930-9 | — | Xi; R38 N; R51-53 | Xi; N R: 38-51/53 S: (2-)36/37-61 | |
602-007-00-X | bromoform; tribromomethane | | 200-854-6 | 75-25-2 | T; R23 Xn; R22 Xi; R36/38 N; R51-53 | T; N R: 22-23-36/38-51/53 S: (1/2-)28-45-63-61 | |
602-030-00-5 | 1,3-dichloropropene; [1] (Z)-1,3-dichloropropene [2] | C D | 208-826-5 [1] 233-195-8 [2] | 542-75-6 [1] 10061-01-5 [2] | R10 T; R24/25 Xn; R20-65 Xi; R36/37/38 R43 N; R50-53 | T; N R: 10-20-24/25-36/37/38-43-65-50/53 S: (1/2-)36/37-45-60-61 | |
602-054-00-6 | 3-iodpropene; allyl iodide | | 209-130-4 | 556-56-9 | F; R11 C; R34 | F; C R: 11-34 S: (1/2-)7-16-26-45 | |
603-005-00-1 | 2-methylpropan-2-ol; tert-butyl alcohol | | 200-889-7 | 75-65-0 | F; R11 Xn; R20 Xi; R36/37 | F; Xn R: 11-20-36/37 S: (2-)9-16-46 | |
603-018-00-2 | furfuryl alcohol | | 202-626-1 | 98-00-0 | Carc. Cat. 3; R40 T; R23 Xn; R21/22-48/20 Xi; R36/37 | T R: 21/22-23-36/37-40-48/20 S: (1/2-)36/37-45-63 | |
603-023-00-X | ethylene oxide; oxirane | E | 200-849-9 | 75-21-8 | F+; R12 R6 Carc. Cat. 2; R45 Muta. Cat. 2; R46 T; R23 Xi; R36/37/38 | F+; T R: 45-46-6-12-23-36/37/38 S: 53-45 | |
603-029-00-2 | bis(2-chloroethyl) ether | | 203-870-1 | 111-44-4 | Carc. Cat. 3; R40 T+; R26/27/28 | T+ R: 26/27/28-40 S: (1/2-)7/9-27-28-36/37-45 | C ≥ 7 %: T+; R26/27/28-40 1 % ≤ C < 7 %: T; R23/24/25-40 0,1 % ≤ C < 1 %: Xn; R20/21/22 |
603-037-00-6 | cellulose nitrate; nitrocellulose | T | — | — | E; R3 | E R: 3 S: (2-)35 | |
603-046-00-5 | bis(chloromethyl) ether; oxybis(chloromethane) | E | 208-832-8 | 542-88-1 | F; R11 Carc. Cat. 1; R45 T+; R26 T; R24 Xn; R22 | F; T+ R: 45-11-22-24-26 S: 53-45 | C ≥ 25 %: T+; R45-22-24-26 7 % ≤ C < 25 %: T+; R45-21-26 3 % ≤ C < 7 %: T; R45-21-23 1 % ≤ C < 3 %: T; R45-23 0,1 % ≤ C < 1 %: T; R45-20 0,001 % ≤ C < 0,1 %: T; R45 |
603-064-00-3 | 1-methoxy-2-propanol; monopropylene glycol methyl ether | | 203-539-1 | 107-98-2 | R10 R67 | R: 10-67 S: (2-) | |
603-066-00-4 | 1,2-epoxy-4-epoxyethylcyclohexane; 4-vinylcyclohexene diepoxide | | 203-437-7 | 106-87-6 | Carc. Cat. 3; R40 T; R23/24/25 | T R: 23/24/25-40 S: (1/2-)36/37-45-63 | C ≥ 1 %: T; R23/24/25-40 0,1 % ≤ C < 1 %: Xn; R20/21/22 |
605-004-00-1 | 2,4,6-trimethyl-1,3,5-trioxane; paraldehyde | | 204-639-8 | 123-63-7 | R10 | R: 10 S: (2-)29 | |
605-005-00-7 | 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane; metaldehyde | | 203-600-2 | 108-62-3 | F; R11 Xn; R22 | F; Xn R: 11-22 S: (2-)13-16-25-46 | |
606-021-00-7 | N-methyl-2-pyrrolidone; 1-methyl-2-pyrrolidone | | 212-828-1 | 872-50-4 | Repr. Cat. 2; R61 Xi; R36/37/38 | T R: 61-36/37/38 S: 53-45 | C ≥ 10 %: T; R61-36/37/38 5 % ≤ C < 10 %: T; R61 |
607-007-00-3 | salts of oxalic acid with the exception of those specified elsewhere in this Annex | A | — | — | Xn; R21/22 | Xn R: 21/22 S: (2-)24/25 | C ≥ 5 %: Xn; R21/22 |
607-012-00-0 | benzoyl chloride | | 202-710-8 | 98-88-4 | Xn; R20/21/22 C; R34 R43 | C R: 20/21/22-34-43 S: (1/2-)26-36/37/39-45 | |
607-037-00-7 | 2-ethoxyethyl acetate; ethylglycol acetate | E | 203-839-2 | 111-15-9 | R10 Repr. Cat. 2; R60-61 Xn; R20/21/22 | T R: 60-61-10-20/21/22 S: 53-45 | |
607-051-00-3 | MCPA (ISO); 4-chloro-o-tolyloxyacetic acid | | 202-360-6 | 94-74-6 | Xn; R22 Xi; R38-41 N; R50-53 | Xn; N R: 22-38-41-50/53 S: (2-)26-37-39-60-61 | |
607-052-00-9 | salts and esters of MCPA | A | — | — | Xn; R20/21/22 N; R50-53 | Xn; N R: 20/21/22-50/53 S: (2-)13-60-61 | |
607-085-00-9 | benzyl benzoate | | 204-402-9 | 120-51-4 | Xn; R22 N; R51-53 | Xn; N R: 22-51/53 S: (2-)25-46-61 | |
607-095-00-3 | maleic acid | | 203-742-5 | 110-16-7 | Xn; R22 Xi; R36/37/38 R43 | Xn R: 22-36/37/38-43 S: (2-)24-26-28-37-46 | C ≥ 25 %: Xn; R22-36/37/38-43 20 % ≤ C <25 %: Xi; R36/37/38-43 0,1 % ≤ C < 20 %: Xi; R43 |
607-103-00-5 | succinic anhydride | | 203-570-0 | 108-30-5 | Xn; R22 Xi; R36/37 | Xn R: 22-36/37 S: (2-)25-46 | C ≥ 5 %: Xn; R22-36/37 1 % ≤ C < 5 %: Xi; R36/37 |
607-142-00-8 | propyl chloroformate; chloroformic acid propylester; n-propyl chloroformate | | 203-687-7 | 109-61-5 | F; R11 T; R23 C; R34 | F; T R: 11-23-34 S: (1/2-)16-26-36-45 | |
607-195-00-7 | 2-methoxy-1-methylethyl acetate | | 203-603-9 | 108-65-6 | R10 | R: 10 S: (2-) | |
607-216-00-X | glutamic acid, reaction products with N-(C 12-14-alkyl)propylenediamine | | 403-950-8 | — | T+; R26 Xn; R22 C; R34 N; R50 | T+; N R: 22-26-34-50 S: (1/2-)26-36/37/39-38-45-61 | |
607-231-00-1 | clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid | | 216-935-4 | 1702-17-6 | Xi; R41 | Xi R: 41 S: (2-)26-39 | |
607-245-00-8 | tert-butyl acrylate | D | 216-768-7 | 1663-39-4 | F; R11 Xn; R20/21/22 Xi; R37/38 R43 N; R51-53 | F; Xn; N R: 11-20/21/22-37/38-43-51/53 S: (2-)16-25-37-61 | C ≥ 25 %: Xn; R20/21/22-37/38-43-51/53 20 % ≤ C < 25 %: Xi; R37/38-43-52/53 2,5 % ≤ C < 20 %: Xi; R43-52/53 1 % ≤ C < 2,5 %: Xi; R43 |
607-397-00-5 | A mixture of: Ca salicylates (branched C 10-14 and C 18-30 alkylated); Ca phenates (branched C 10-14 and C 18-30 alkylated); Ca sulfurised phenates (branched C 10-14 and C 18-30 alkylated) | | 415-930-6 | — | Repr. Cat. 3; R62 R43 | Xn R: 43-62 S: (2-)23-36/37 | |
608-005-00-5 | n-butyronitrile | | 203-700-6 | 109-74-0 | F; R11 T; R23/24/25 | F; T R: 11-23/24/25 S: (1/2-)16-36/37-45-63 | |
608-011-00-8 | oxalonitrile; cyanogen | | 207-306-5 | 460-19-5 | F+; R12 T; R23 N; R50-53 | F+; T; N R: 12-23-50/53 S: (1/2-)9-16-23-33-45-63-60-61 | |
608-044-00-8 | 2-cyclohexylidene-2-phenylacetonitrile | | 423-740-1 | 10461-98-0 | Xn; R22 N; R51-53 | Xn; N R; 22-51/53 S: (2-)46-61 | |
609-007-00-9 | 2,4-dinitrotoluene; [1] dinitrotoluene [2] | E | 204-450-0 [1] 246-836-1 [2] | 121-14-2 [1] 25321-14-6 [2] | Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T; R23/24/25 Xn; R48/22 N; R50-53 | T; N R: 45-23/24/25-48/22-62-68-50/53 S: 53-45-60-61 | |
611-028-00-3 | C,C′-azodi(formamide) | | 204-650-8 | 123-77-3 | E; R2 R42 | E; Xn R: 2-42 S: (2-)22-24-37 | |
611-035-00-1 | tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate | | 403-660-1 | 107246-80-0 | N; R51-53 | N R: 51/53 S: 61 | |
612-044-00-3 | N,N′-diacetylbenzidine | E | 210-338-2 | 613-35-4 | Carc. Cat. 2; R45 Muta. Cat. 3; R68 Xn; R20/21/22 | T R: 45-20/21/22-68 S: 53-45 | |
612-050-00-6 | cyclohexylamine | | 203-629-0 | 108-91-8 | R10 Repr. Cat. 3; R62 Xn; R21/22 C; R34 | C R: 10-21/22-34-62 S: (1/2-)26-36/37/39-45 | C ≥ 25 %: C; R21/22-34-62 10 % ≤ C < 25 %: C; R34-62 5 % ≤ C < 10 %: Xn; R36/38-62 2 % ≤ C < 5 %: Xi; R36/38 |
612-076-00-8 | ethyldimethylamine | | 209-940-8 | 598-56-1 | F; R11 Xn; R20/22 C; R34 | F; C R: 11-20/22-34 S: (1/2-)3-16-26-36-45 | |
612-099-00-3 | 4-methyl-m-phenylenediamine; 2,4-toluenediamine | E | 202-453-1 | 95-80-7 | Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T; R25 Xn; R21-48/22 R43 N; R51-53 | T; N R: 45-21-25-43-48/22-62-68-51/53 S: 53-45-61 | |
612-101-00-2 | methenamine; hexamethylenetetramine | | 202-905-8 | 100-97-0 | F; R11 R43 | F; Xi R: 11-43 S: (2-)24-37 | |
612-151-00-5 | methyl-phenylene diamine; diaminotoluene; [technical product - mixture of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)] | E | — | — | Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 T; R25 Xn; R21-48/22 Xi; R36 R43 N; R51-53 | T; N R: 45-21-25-36-43-48/22-62-68-51/53 S: 53-45-61 | |
612-237-00-2 | hydroxylammonium hydrogensulfate; hydroxylamine sulfate(1:1); [1] hydroxylamine phosphate; [2] hydroxylamine dihydrogenphosphate; [3] hydroxylamine 4-methylbenzenesulfonate [4] | T | 233-154-4 [1] 244-077-0 [2] 242-818-2 [3] 258-872-5 [4] | 10046-00-1 [1] 20845-01-6 [2] 19098-16-9 [3] 53933-48-5 [4] | E; R2 Carc. Cat. 3; R40 Xn; R21/22-48/22 Xi; R36/38 R43 N; R50 | E; Xn; N R: 21/22-36/38-40-43-48/22-50 S: (2-)36/37-61 | |
613-116-00-7 | tolylfluanid (ISO); dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | | 211-986-9 | 731-27-1 | T+; R26 T; R48/23 Xi; R36/37/38 R43 N; R50 | T+; N R: 26-36/37/38-43-48/23-50 S: (1/2-)28-36/37/39-45-63-61 | C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-50 10 % ≤ C < 20 %: T+, N; R26-43-48/23-50 7 % ≤ C < 10 %: T+, N; R26-43-48/20-50 2,5 % ≤ C < 7 %: T, N; R23-43-48/20-50 1 % ≤ C < 2,5 %: T; R23-43-48/20 0,1 % ≤ C < 1 %: Xn; R20 |
615-001-00-7 | methyl isocyanate | | 210-866-3 | 624-83-9 | F; R11 Repr. Cat. 3; R63 T+; R26 T; R24/25 R42/43 Xi; R37/38-41 | F; T+ R: 11-24/25-26-37/38-41-42/43-63 S: (1/2-)16-26-27/28-36/37/39-45-63 | |
615-004-00-3 | salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | A | — | — | Xn; R20/21/22 R32 R52-53 | Xn R: 20/21/22-32-52/53 S: (2-)13-36/37-46-61 | |
615-028-00-4 | ethyl 2-(isocyanatosulfonyl)benzoate | | 410-220-2 | 77375-79-2 | R14 Xn; R22-48/22 Xi; R41 R42/43 | Xn R: 14-22-41-42/43-48/22 S: (2-)8-23-26-30-35-36/37/39 | |
615-030-00-5 | alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | A | — | — | Xn; R20/21/22 R32 R52-53 | Xn R: 20/21/22-32-52/53 S: (2-)13-36/37-46-61 | |
615-031-00-0 | thallium thiocyanate | | 222-571-7 | 3535-84-0 | T+; R26/28 Xn; R21 R32 R33 N; R51-53 | T+; N R: 21-26/28-32-33-51/53 S: (1/2-)13-28-36/37-45-61 | |
615-032-00-6 | metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | A | — | — | Xn; R20/21/22 R32 N; R50-53 | Xn; N R: 20/21/22-32-50/53 S: (2-)13-36/37-46-60-61 | |
616-124-00-9 | lithium bis(trifluoromethylsulfonyl)imide | | 415-300-0 | 90076-65-6 | T; R24/25 Xn; R48/22 C; R34 R52-53 | T R: 24/25-34-48/22-52/53 S: (1/2-)22-26-36/37/39-45-61 | |
617-017-00-X | A mixture of: 2,2′-bis(tert-pentylperoxy)-p-diisopropylbenzene; 2,2′-bis(tert-pentylperoxy)-m-diisopropylbenzene | T | 412-140-3 | 32144-25-5 | E; R2 O; R7 R53 | E R: 2-7-53 S: (2-)3/7-14-36/37/39-61 | |
650-016-00-2 | Mineral wool, with the exception of those specified elsewhere in this Annex; [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight] | AQR | — | — | Carc. Cat. 3; R40 | Xn R: 40 S: (2-)36/37 | |
650-017-00-8 | Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex; [Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight] | AR | — | — | Carc. Cat. 2; R49 | T R: 49 S: 53-45 | |
ANNEX 1B
Index No | Chemical name | Notes related to substances | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes related to preparations
003-003-00-5 | (2-methylpropyl)lithium; isobutyllithium | | 440-620-2 | 920-36-5 | F; R15-17 R14 C; R35 R67 N; R50-53 | F; C; N R: 14/15-17-35-67-50/53 S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61 | |
005-013-00-5 | diethylmethoxyborane | | 425-380-9 | 7397-46-8 | F; R17 Xn; R20/21/22-48/22 C; R34 R43 R53 | F; C R: 17-20/21/22-34-43-48/22-53 S: (1/2-)6-26-36/37/39-43-45-61 | |
005-014-00-0 | 4-formylphenylboronic acid | | 438-670-5 | 87199-17-5 | R43 | Xi R: 43 S: (2-)24-37 | |
005-017-00-7 | sodium perborate; [1] perboric acid, sodium salt; [2] perboric acid, sodium salt, monohydrate; [3] sodium peroxometaborate; [4] perboric acid (HBO(O2)), sodium salt, monohydrate; [5] sodium peroxoborate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | E | 239-172-9 [1] 234-390-0 [2] - [3] 231-556-4 [4] - [5] | 15120-21-5 [1] 11138-47-9 [2] 12040-72-1 [3] 7632-04-4 [4] 10332-33-9 [5] | O; R8 Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xn; R22 Xi; R37-41 | O; T R: 61-8-22-37-41-62 S: 53-45 | C ≥ 25 %: T; R61-22-37-41-62 22 % ≤ C < 25 %: T; R61-37-41-62 20 % ≤ C < 22 %: T; R61-36/37-62 14 % ≤ C < 20 %: T; R61-36-62 9 % ≤ C < 14 %: T; R61-62 6,5 % ≤ C < 9 %: T; R61 |
005-017-01-4 | sodium perborate; [1] perboric acid, sodium salt; [2] perboric acid, sodium salt, monohydrate; [3] sodium peroxometaborate; [4] perboric acid (HBO(O2)), sodium salt, monohydrate; [5] sodium peroxoborate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | E | 239-172-9 [1] 234-390-0 [2] - [3] 231-556-4 [4] - [5] | 15120-21-5 [1] 11138-47-9 [2] 12040-72-1 [3] 7632-04-4 [4] 10332-33-9 [5] | O; R8 Repr. Cat. 2; R61 Repr. Cat. 3; R62 T; R23 Xn; R22 Xi; R37-41 | O; T R: 61-8-22-23-37-41-62 S: 53-45 | C ≥ 25 %: T; R61-22-23-37-41-62 22 % ≤ C < 25 %: T; R61-20-37-41-62 20 % ≤ C < 22 %: T; R61-20-36/37-62 14 % ≤ C < 20 %: T; R61-20-36-62 9 % ≤ C < 14 %: T; R61-20-62 6,5 % ≤ C < 9 %: T; R61-20 3 % ≤ C < 6,5 %: Xn; R20 |
005-018-00-2 | perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] sodium peroxoborate hexahydrate; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | | - [1] - [2] - [3] | 13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] | Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xi; R37-41 | T R: 61-37-41-62 S: 53-45-47 | C ≥ 36 %: T; R61-37-41-62 22 % ≤ C < 36 %: T; R61-36/37-62 20 % ≤ C < 22 %: T; R61-37-62 14 % ≤ C < 20 %: T; R61-62 10 % ≤ C < 14 %: T; R61 |
005-018-01-X | perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1] perboric acid, sodium salt, tetrahydrate; [2] perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3] sodium peroxoborate hexahydrate; [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | E | - [1] - [2] - [3] | 13517-20-9 [1] 37244-98-7 [2] 10486-00-7 [3] | Repr. Cat. 2; R61 Repr. Cat. 3; R62 Xn; R20 Xi; R37-41 | T R: 61-20-37-41-62 S: 53-45-47 | C ≥ 36 %: T; R61-20-37-41-62 25 % ≤ C < 36 %: T; R61-20-36/37-62 22 % ≤ C < 25 %: T; R61-36/37-62 20 % ≤ C < 22 %: T; R61-37-62 14 % ≤ C < 20 %: T; R61-62 10 % ≤ C < 14 %: T; R61 |
006-097-00-6 | 1-phenyl-3-(p-toluenesulfonyl)urea | | 424-620-1 | 13909-63-2 | Xn; R22-48/22 R52-53 | Xn R: 22-48/22-52/53 S: (2-)22-36-61 | |
006-098-00-1 | tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate | | 429-170-8 | 134575-17-0 | Xn; R22-48/22 Xi; R41 R43 | Xn R: 22-41-43-48/22 S: (2-)22-26-36/37/39 | |
006-099-00-7 | N-(p-toluenesulfonyl)-N′-(3-(p-toluenesulfonyloxy)phenyl)urea; 3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate | | 432-520-2 | 232938-43-1 | N; R51-53 | N R: 51/53 S: 22-61 | |
006-101-00-6 | mixture of: N,N″-(methylenedi-4,1-phenylene)bis[N′-phenylurea]; N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N′-cyclohexylurea; N,N″-(methylenedi-4,1-phenylene)bis[N′-cyclohexylurea] | | 423-070-8 | — | R53 | R: 53 S: 61 | |
006-102-00-1 | O-hexyl-N-ethoxycarbonylthiocarbamate | E | 432-750-3 | — | Carc. Cat. 2; R45 Muta. Cat. 2; R46 Xn; R22-48/22 R43 N; R51-53 | T; N R: 45-46-22-43-48/22-51/53 S: 53-45-61 | |
006-103-00-7 | N,N″-(methylenedi-4,1-phenylene)bis[N′-octyl]urea | | 445-760-8 | — | Xi; R41 R42 N; R50-53 | Xn; N R: 41-42-50/53 S: (2-)22-26-39-45-60-61 | C ≥10 %: Xn, N; R41-42-50/53 5 % ≤ C < 10 %: Xn, N; R36-42-50/53 1 % ≤ C < 5 %: Xn, N; R42-50/53 0,25 % ≤ C < 1 %: N; R50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 ≤ C < 0,025 %: R52/53 |
007-029-00-8 | diethyldimethylammonium hydroxide | | 419-400-5 | 95500-19-9 | Xn; R21/22 C; R35 | C R: 21/22-35 S: (1/2-)26-36/37/39-45 | |
012-004-00-X | aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate | | 422-150-1 | — | N; R50-53 | N R: 50/53 S: 60-61 | |
014-036-00-X | (4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane | | 405-020-7 | 105024-66-6 | Repr.Cat.2; R60 N; R50-53 | T; N R: 60-50/53 S: 53-45-60-61 | C ≥ 0,5 %: T, N; R60-50/53 0,025 % ≤ C < 0,5 %: N; R50/53 0,0025 % ≤ C < 0,025 %: N; R51/53 0,00025 % ≤ C < 0,0025 %: R52/53 |
014-037-00-5 | 2-butanone-O,O′,O′′-(phenylsilylidyne)trioxime | | 433-360-6 | 34036-80-1 | Xn; R48/22 R43 R52-53 | Xn R: 43-48/22-52/53 S: (2-)36/37-61 | |
014-038-00-0 | S-(3-(triethoxysilyl)propyl)octanethioate | | 436-690-9 | 220727-26-4 | R43 | Xi R: 43 S: (2-)24-37 | |
014-039-00-6 | (2,3-dimethylbut-2-yl)-trimethoxysilane | | 439-360-2 | 142877-45-0 | Xi; R38-41 R52-53 | Xi R: 38-41-52/53 S: (2-)26-37/39-61 | |
014-041-00-7 | N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane | | 445-890-5 | 201290-01-9 | Xn; R22 R43 | Xn R: 22-43 S: (2-)24-37 | |
014-042-00-2 | mixture of: O,O′,O″,O′′′-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers) | | 423-010-0 | — | Xi; R41 | Xi R: 41 S: (2-)26-39 | |
014-043-00-8 | reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %) | | 432-200-2 | — | F; R11 Xi; R37/38-41 R52-53 | F; Xi R: 11-37/38-41-52/53 S: (2-)6-26-36/39-61 | |
014-044-00-3 | 3-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilane | | 433-050-0 | — | N; R51-53 | N R: 51/53 S: 61 | |
014-045-00-9 | magnesium sodium fluoride silicate | | 442-650-1 | — | Xn; R48/20 | Xn R: 48/20 S: (2-)22-36 | |
015-190-00-0 | bis(2,4-dicumylphenyl) neopentyl diphosphite; 3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane | | 421-920-2 | 154862-43-8 | R53 | R: 53 S: 61 | |
015-191-00-6 | dodecyldiphenyl phosphate | | 431-760-5 | 27460-02-2 | Xi; R38 R52-53 | Xi R: 38-52/53 S: (2-)37-61 | |
015-192-00-1 | tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate | | 432-770-2 | 139189-30-3 | R43 R53 | Xi R: 43-53 S: (2-)24-37-61 | |
015-193-00-7 | triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1) | | 442-960-7 | 332350-93-3 | T; R25 Xi; R41 N; R50-53 | T; N R: 25-41-50/53 S: (1/2-)26-39-45-60-61 | |
015-194-00-2 | tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate | | 444-440-5 | 220689-12-3 | Xn; R22 R52-53 | Xn R: 22-52/53 S: (2-)61 | |
015-195-00-8 | mixture of: potassium o-toluenephosphonate; potassium m-toluenephosphonate; potassium p-toluenephosphonate | | 433-860-4 | — | Xi; R36 R43 R52-53 | Xi R: 36-43-52/53 S: (2-)24-26-37-61 | |
015-196-00-3 | mixture of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate; methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate | | 435-960-3 | — | Carc.Cat.2; R45 Muta.Cat.2; R46 R43 | T R: 45-46-43 S: 53-45 | |
015-197-00-9 | bis(2,4,4-trimethylpentyl)dithiophosphonic acid | | 420-160-9 | 107667-02-7 | R10 T; R23 Xn; R22 C; R34 N; R51-53 | T; N R: 10-22-23-34-51/53 S: (1/2-)9-26-36/37/39-45-61 | |
015-198-00-4 | (4-phenylbutyl)phosphinic acid | | 420-450-5 | 86552-32-1 | Carc.Cat.3; R40 Xi; R41 | Xn R: 40-41 S: (2-)23-26-36/37/39 | |
016-094-00-1 | sulfur | | 231-722-6 | 7704-34-9 | Xi; R38 | Xi R: 38 S: (2-)46 | |
016-097-00-8 | 1-amino-2-methyl-2-propanethiol hydrochloride | | 434-480-1 | 32047-53-3 | Xn; R22 C; R34 R43 R52-53 | C R: 22-34-43-52/53 S: (1/2-)22-26-36/37/39-45-61 | |
017-009-01-8 | ammonium perchlorate; [containing < 80 % of 0-30 μm particles] | T | 232-235-1 | 7790-98-9 | E; R2 O; R9 | E R: 2-9 S: (2-)14-16-36/37 | |
022-004-00-1 | potassium titanium oxide (K2Ti6O 13) | | 432-240-0 | 12056-51-8 | Carc.Cat.3; R40 | Xn R: 40 S: (2-)22-36/37 | |
022-005-00-7 | [N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κ N][(1,2,3,4-η)-1,3-pentadiene]-titanium | | 419-840-8 | 169104-71-6 | F; R11 C; R34 R43 R53 | F; C R: 11-34-43-53 S: (1/2-)6-9-16-26-36/37/39-45-61 | |
028-002-01-4 | nickel powder; [particle diameter < 1 mm] | | 231-111-4 | 7440-02-0 | Carc. Cat. 3; R40 T; R48/23 R43 R52-53 | T R: 40-43-48/23-52/53 S: (2-)36/37/39-45-61 | |
028-013-00-7 | nickel matte | E, H | 273-749-6 | 69012-50-6 | Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 | T; N R: 49-43-48/23-50/53 S: 53-45-60-61 | |
028-014-00-2 | slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate | E | 295-859-3 | 92129-57-2 | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 Xn; R20/22 Xi; R38 R42/43 N; R50-53 | T; N R: 49-61-20/22-38-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/53 20 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/53 2,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-015-00-8 | slimes and sludges, copper electrolyte refining, decopperised | E, H | 305-433-1 | 94551-87-8 | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 1; R61 Repr. Cat. 3; R62 T; R48/23 R42/43 N; R50-53 | T; N R: 49-61-42/43-48/23-62-68-50/53 S: 53-45-60-61 | |
028-016-00-3 | nickel diperchlorate; perchloric acid, nickel(II) salt | E, H | 237-124-1 | 13637-71-3 | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 C; R34 R42/43 N; R50-53 | T; N R: 49-61-34-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/53 5 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/53 2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-017-00-9 | nickel dipotassium bis(sulfate); [1] diammonium nickel bis(sulfate) [2] | E, H | 237-563-9 [1] 239-793-2 [2] | 13842-46-1 [1] 15699-18-0 [2] | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 Xn; R20/22 R42/43 N; R50-53 | T; N R: 49-61-20/22-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-018-00-4 | nickel bis(sulfamidate); nickel sulfamate | E, H | 237-396-1 | 13770-89-3 | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 | T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-019-00-X | nickel bis(tetrafluoroborate) | E, H | 238-753-4 | 14708-14-6 | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 | T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-021-00-0 | nickel diformate; [1] formic acid, nickel salt; [2] formic acid, copper nickel salt [3] | E, H | 222-101-0 [1] 239-946-6 [2] 268-755-0 [3] | 3349-06-2 [1] 15843-02-4 [2] 68134-59-8 [3] | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 | T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5%: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C 0,1 %: Xi; R43 |
028-022-00-6 | nickel di(acetate); [1] nickel acetate [2] | E, H | 206-761-7 [1] 239-086-1 [2] | 373-02-4 [1] 14998-37-9 [2] | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 Xn; R20/22 R42/43 N; R50-53 | T; N R: 49-61-20/22-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-024-00-7 | nickel dibenzoate | E, H | 209-046-8 | 553-71-9 | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 | T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-025-00-2 | nickel bis(4-cyclohexylbutyrate) | E, H | 223-463-2 | 3906-55-6 | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 | T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-026-00-8 | nickel(II) stearate; nickel(II) octadecanoate | E, H | 218-744-1 | 2223-95-2 | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 | T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-027-00-3 | nickel dilactate | E, H | — | 16039-61-5 | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 | T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-028-00-9 | nickel(II) octanoate | E, H | 225-656-7 | 4995-91-9 | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat 2; R61 T; R48/23 C; R35 R42/43 N; R50-53 | T; C; N R: 49-61-35-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/53 10 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/53 5 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/53 2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-029-00-4 | nickel difluoride; [1] nickel dibromide; [2] nickel diiodide; [3] nickel potassium fluoride [4] | E, H | 233-071-3 [1] 236-665-0 [2] 236-666-6 [3] - [4] | 10028-18-9 [1] 13462-88-9 [2] 13462-90-3 [3] 11132-10-8 [4] | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 | T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-030-00-X | nickel hexafluorosilicate | E, H | 247-430-7 | 26043-11-8 | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 | T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-031-00-5 | nickel selenate | E, H | 239-125-2 | 15060-62-5 | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 | T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-032-00-0 | nickel hydrogen phosphate; [1] nickel bis(dihydrogen phosphate); [2] trinickel bis(orthophosphate); [3] dinickel diphosphate; [4] nickel bis(phosphinate); [5] nickel phosphinate; [6] phosphoric acid, calcium nickel salt; [7] diphosphoric acid, nickel(II) salt [8] | E, H | 238-278-2 [1] 242-522-3 [2] 233-844-5 [3] 238-426-6 [4] 238-511-8 [5] 252-840-4 [6] - [7] - [8] | 14332-34-4 [1] 18718-11-1 [2] 10381-36-9 [3] 14448-18-1 [4] 14507-36-9 [5] 36026-88-7 [6] 17169-61-8 [7] 19372-20-4 [8] | Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 | T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 | |
028-033-00-6 | diammonium nickel hexacyanoferrate | E, H | — | 74195-78-1 | Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 | T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 | |
028-034-00-1 | nickel dicyanide | E, H | 209-160-8 | 557-19-7 | Carc. Cat. 1; R49 T; R48/23 R42/43 R32 N; R50-53 | T; N R: 49-32-42/43-48/23-50/53 S: 53-45-60-61 | |
028-035-00-7 | nickel chromate | E, H | 238-766-5 | 14721-18-7 | Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 | T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 | |
028-036-00-2 | nickel(II) silicate; [1] dinickel orthosilicate; [2] nickel silicate (3:4); [3] silicic acid, nickel salt; [4] trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5] | E, H | 244-578-4 [1] 237-411-1 [2] 250-788-7 [3] 253-461-7 [4] 235-688-3 [5] | 21784-78-1 [1] 13775-54-7 [2] 31748-25-1 [3] 37321-15-6 [4] 12519-85-6 [5] | Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 | T; N R: 49-43-48/23-50/53 S: 53-45-60-61 | |
028-037-00-8 | dinickel hexacyanoferrate | E, H | 238-946-3 | 14874-78-3 | Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 | T; N R: 49-43-48/23-50/53 S: 53-45-60-61 | |
028-038-00-3 | trinickel bis(arsenate); nickel(II) arsenate | E, H | 236-771-7 | 13477-70-8 | Carc. Cat. 1; R45 T; R48/23 R43 N; R50-53 | T; N R: 45-43-48/23-50/53 S: 53-45-60-61 | |
028-039-00-9 | nickel oxalate; [1] oxalic acid, nickel salt [2] | E, H | 208-933-7 [1] 243-867-2 [2] | 547-67-1 [1] 20543-06-0 [2] | Carc. Cat. 1; R49 T; R48/23 R43 N: R50-53 | T; N R: 49-43-48/23-50/53 S: 53-45-60-61 | |
028-040-00-4 | nickel telluride | E, H | 235-260-6 | 12142-88-0 | Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 | T; N R: 49-43-48/23-50/53 S: 53-45-60-61 | |
028-041-00-X | trinickel tetrasulfide | E, H | — | 12137-12-1 | Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 | T; N R: 49-43-48/23-50/53 S: 53-45-60-61 | |
028-042-00-5 | trinickel bis(arsenite) | E, H | — | 74646-29-0 | Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 | T; N R: 49-43-48/23-50/53 S: 53-45-60-61 | |
028-043-00-0 | cobalt nickel gray periclase; C.I. Pigment Black 25; C.I. 77332; [1] cobalt nickel dioxide; [2] cobalt nickel oxide [3] | E, H | 269-051-6 [1] 261-346-8 [2] - [3] | 68186-89-0 [1] 58591-45-0 [2] 12737-30-3 [3] | Carc. Cat. 1; R49 T; R48/23 R43 | T R: 49-43-48/23 S: 53-45 | |
028-044-00-6 | nickel tin trioxide; nickel stannate | E, H | 234-824-9 | 12035-38-0 | Carc. Cat. 1; R49 T; R48/23 R43 | T R: 49-43-48/23 S: 53-45 | |
028-045-00-1 | nickel triuranium decaoxide | E, H | 239-876-6 | 15780-33-3 | Carc. Cat. 1; R49 T; R48/23 R43 | T R: 49-43-48/23 S: 53-45 | |
028-046-00-7 | nickel dithiocyanate | E, H | 237-205-1 | 13689-92-4 | Carc. Cat. 1; R49 Muta. Cat. 3;R68 Repr. Cat. 2; R61 T; R48/23 R42/43 R32 N; R50-53 | T; N R: 49-61-32-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-047-00-2 | nickel dichromate | E, H | 239-646-5 | 15586-38-6 | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 | T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1% ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C 0,1 %: Xi; R43 |
028-048-00-8 | nickel(II) selenite | E, H | 233-263-7 | 10101-96-9 | Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 | T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 | |
028-049-00-3 | nickel selenide | E, H | 215-216-2 | 1314-05-2 | Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 | T; N R: 49-43-48/23-50/53 S: 53-45-60-61 | |
028-050-00-9 | silicic acid, lead nickel salt | E, H | — | 68130-19-8 | Carc. Cat. 1: R49 Repr. Cat. 1: R61 Repr. Cat. 3; R62 T; R48/23 R43 N; R50-53 | T; N R: 49-61-43-48/23-62-50/53 S: 53-45-60-61 | |
028-051-00-4 | nickel diarsenide; [1] nickel arsenide [2] | E, H | 235-103-1 [1] 248-169-1 [2] | 12068-61-0 [1] 27016-75-7 [2] | Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 | T; N R: 49-43-48/23-50/53 S: 53-45-60-61 | |
028-052-00-X | nickel barium titanium primrose priderite; C.I. Pigment Yellow 157; C.I. 77900 | E, H | 271-853-6 | 68610-24-2 | Carc. Cat. 1: R49 T; R48/23 R43 | T R: 49-43-48/23 S: 53-45 | |
028-053-00-5 | nickel dichlorate; [1] nickel dibromate; [2] ethyl hydrogen sulfate, nickel(II) salt [3] | E, H | 267-897-0 [1] 238-596-1 [2] 275-897-7 [3] | 67952-43-6 [1] 14550-87-9 [2] 71720-48-4 [3] | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 | T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T: R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-054-00-0 | nickel(II) trifluoroacetate; [1] nickel(II) propionate; [2] nickel bis(benzenesulfonate); [3] nickel(II) hydrogen citrate; [4] citric acid, ammonium nickel salt; [5] citric acid, nickel salt; [6] nickel bis(2-ethylhexanoate); [7] 2-ethylhexanoic acid, nickel salt; [8] dimethylhexanoic acid nickel salt; [9] nickel(II) isooctanoate; [10] nickel isooctanoate; [11] nickel bis(isononanoate); [12] nickel(II) neononanoate; [13] nickel(II) isodecanoate; [14] nickel(II) neodecanoate; [15] neodecanoic acid, nickel salt; [16] nickel(II) neoundecanoate; [17] bis(D-gluconato-O 1,O 2)nickel; [18] nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19] nickel(II) palmitate; [20] (2-ethylhexanoato-O)(isononanoato-O)nickel; [21] (isononanoato-O)(isooctanoato-O)nickel; [22] (isooctanoato-O)(neodecanoato-O)nickel; [23] (2-ethylhexanoato-O)(isodecanoato-O)nickel; [24] (2-ethylhexanoato-O)(neodecanoato-O)nickel; [25] (isodecanoato-O)(isooctanoato-O)nickel; [26] (isodecanoato-O)(isononanoato-O)nickel; [27] (isononanoato-O)(neodecanoato-O)nickel; [28] fatty acids, C 6-19-branched, nickel salts; [29] fatty acids, C 8-18 and C 18-unsaturated, nickel salts; [30] 2,7-naphthalenedisulfonic acid, nickel(II) salt; [31] | E, H | 240-235-8 [1] 222-102-6 [2] 254-642-3 [3] 242-533-3 [4] 242-161-1 [5] 245-119-0 [6] 224-699-9 [7] 231-480-1 [8] 301-323-2 [9] 249-555-2 [10] 248-585-3 [11] 284-349-6 [12] 300-094-6 [13] 287-468-1 [14] 287-469-7 [15] 257-447-1 [16] 300-093-0 [17] 276-205-6 [18] 258-051-1 [19] 237-138-8 [20] 287-470-2 [21] 287-471-8 [22] 284-347-5 [23] 284-351-7 [24] 285-698-7 [25] 285-909-2 [26] 284-348-0 [27] 287-592-6 [28] 294-302-1 [29] 283-972-0 [30] - [31] | 16083-14-0 [1] 3349-08-4 [2] 39819-65-3 [3] 18721-51-2 [4] 18283-82-4 [5] 22605-92-1 [6] 4454-16-4 [7] 7580-31-6 [8] 93983-68-7 [9] 29317-63-3 [10] 27637-46-3 [11] 84852-37-9 [12] 93920-10-6 [13] 85508-43-6 [14] 85508-44-7 [15] 51818-56-5 [16] 93920-09-3 [17] 71957-07-8 [18] 52625-25-9 [19] 13654-40-5 [20] 85508-45-8 [21] 85508-46-9 [22] 84852-35-7 [23] 84852-39-1 [24] 85135-77-9 [25] 85166-19-4 [26] 84852-36-8 [27] 85551-28-6 [28] 91697-41-5 [29] 84776-45-4 [30] 72319-19-8 [31] | Carc. Cat. 1; R49 Muta. Cat. 3; R68 Repr. Cat. 2; R61 T; R48/23 R42/43 N; R50-53 | T; N R: 49-61-42/43-48/23-68-50/53 S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53 2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53 1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53 0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53 0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53 0,1 % ≤ C < 0,25 %: T; R49-43-48/20 0,01 % ≤ C < 0,1 %: Xi; R43 |
028-055-00-6 | nickel(II) sulfite; [1] nickel tellurium trioxide; [2] nickel tellurium tetraoxide; [3] molybdenum nickel hydroxide oxide phosphate [4] | E, H | 231-827-7 [1] 239-967-0 [2] 239-974-9 [3] 268-585-7 [4] | 7757-95-1 [1] 15851-52-2 [2] 15852-21-8 [3] 68130-36-9 [4] | Carc. Cat. 1; R49 T; R48/23 R42/43 N; R50-53 | T; N R: 49-42/43-48/23-50/53 S: 53-45-60-61 | |
028-056-00-1 | nickel boride (NiB); [1] dinickel boride; [2] trinickel boride; [3] nickel boride; [4] dinickel silicide; [5] nickel disilicide; [6] dinickel phosphide; [7] nickel boron phosphide [8] | E, H | 234-493-0 [1] 234-494-6 [2] 234-495-1 [3] 235-723-2 [4] 235-033-1 [5] 235-379-3 [6] 234-828-0 [7] - [8] | 12007-00-0 [1] 12007-01-1 [2] 12007-02-2 [3] 12619-90-8 [4] 12059-14-2 [5] 12201-89-7 [6] 12035-64-2 [7] 65229-23-4 [8] | Carc. Cat. 1; R49 T; R48/23 R43 N; R50-53 | T; N R: 49-43-48/23-50/53 S: 53-45-60-61 | |
028-057-00-7 | dialuminium nickel tetraoxide; [1] nickel titanium trioxide; [2] nickel titanium oxide; [3] nickel divanadium hexaoxide; [4] cobalt dimolybdenum nickel octaoxide; [5] nickel zirkonium trioxide; [6] molybdenum nickel tetraoxide; [7] nickel tungsten tetraoxide; [8] olivine, nickel green; [9] lithium nickel dioxide; [10] molybdenum nickel oxide; [11] | E, H | 234-454-8 [1] 234-825-4 [2] 235-752-0 [3] 257-970-5 [4] 268-169-5 [5] 274-755-1 [6] 238-034-5 [7] 238-032-4 [8] 271-112-7 [9] - [10] - [11] | 12004-35-2 [1] 12035-39-1 [2] 12653-76-8 [3] 52502-12-2 [4] 68016-03-5 [5] 70692-93-2 [6] 14177-55-0 [7] 14177-51-6 [8] 68515-84-4 [9] 12031-65-1 [10] 12673-58-4 [11] | Carc. Cat. 1; R49 T; R48/23 R43 | T R: 49-43-48/23 S: 53-45 | |
028-058-00-2 | cobalt lithium nickel oxide | E | 442-750-5 | — | Carc. Cat. 1; R49 T+; R26 T; R48/23 R43 N; R50-53 | T+; N R: 49-26-43-48/23-50/53 S: 53-45-60-61 | |
029-014-00-5 | mixture of: 2,2′-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N′,O,O′-copper complex; 2,2′-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N′,O,O′-copper complex | | 419-610-7 | 171866-24-3 | Xn; R48/22 N; R51-53 | Xn; N R: 48/22-51/53 S: (2-)22-36-61 | |
030-012-00-1 | aluminium-magnesium-zinc-carbonate-hydroxide | | 423-570-6 | 169314-88-9 | R52-53 | R: 52/53 S: 61 | |
030-015-00-8 | tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate | | 440-060-9 | — | N; R51-53 | N R: 51/53 S: 61 | |
042-005-00-0 | mixture of: mono- and di-glycerols of canola oil; canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl]; N,N-diorgano dithiocarbamate molybdenum complex | | 434-240-6 | — | R43 N; R51-53 | Xi; N R: 43-51/53 S: (2-)24-37-61 | |
050-023-00-5 | mixture of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-phenyl-1,3-decanedionyl)dioctyl stannane; ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane | | 422-920-5 | — | Xn; R48/22 N; R50-53 | Xn; N R: 48/22-50/53 S: (2-)23-36-60-61 | C ≥ 10 %: Xn, N; R48/22-50/53 2,5 % ≤ C < 10 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
050-024-00-0 | mixture of: tri-p-tolyltin hydroxide; hexa-p-tolyl-distannoxane | | 432-230-6 | — | T; R48/25 Xn; R22 Xi; R38-41 R43 N; R50-53 | T; N R: 22-38-41-43-48/25-50/53 S: (1/2-)22-26-36/37/39-45-60-61 | |
064-001-00-8 | gadolinium(III)sulfite trihydrate | | 456-900-2 | 51285-81-5 | N; R51-53 | N R: 51/53 S: 61 | |
078-011-00-5 | hydroxydisulfito platinum(II) acid | | 423-310-1 | 61420-92-6 | Xn; R22-48/20/21/22 C; R35 R42/43 R52-53 | C R: 22-35-42/43-48/20/21/22-52/53 S: (1/2-)23-24-26-28-36/37/39-45-61 | |
078-012-00-0 | platinum(IV) nitrate/nitric acid solution | | 432-400-1 | — | C; R35 N; R50-53 | C; N R: 35-50/53 S: (1/2-)26-36/37/39-45-60-61 | |
082-012-00-6 | barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped | | 431-780-4 | 199876-46-5 | Xn; R22-48/22 N; R51-53 | Xn; N R: 22-48/22-51/53 S: (2-)22-36-61 | |
601-080-00-5 | mixture of: sec-butylphenyl(phenyl)methane, mixed isomers; 1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers; 1-(sec-butylphenyl-1-phenylethane, mixed isomers | | 431-100-6 | — | N; R50-53 | N R: 50/53 S: 60-61 | |
601-081-00-0 | cyclohexadeca-1,9-diene | | 431-730-1 | 4277-06-9 | Xi; R38 R43 R53 | Xi R: 38-43-53 S: (2-)36/37-61 | |
601-082-00-6 | mixture of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane; exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane | | 434-420-4 | — | Xi; R38-41 N; R50-53 | Xi; N R: 38-41-50/53 S: (2-)23-26-37/39-57-60-61 | |
601-083-00-1 | 5-endo-hexyl-bicyclo[2.2.1]hept-2-ene | | 435-000-3 | 22094-83-3 | Xn; R65 Xi; R38 R53 | Xn R: 38-65-53 S: (2-)37-62-61 | |
601-084-00-7 | mixture of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene; 5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20) | | 435-180-3 | — | Xn; R65 Xi; R38 N; R50-53 | Xn; N R: 38-65-50/53 S: (2-)37-62-60-61 | |
602-105-00-2 | sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate | | 422-100-7 | 102061-82-5 | Xi; R41 R43 | Xi R: 41-43 S: (2-)24-26-37/39 | |
602-106-00-8 | 2-bromo-4,6-difluoroaniline | | 429-430-0 | 444-14-4 | Xn; R22 N; R51-53 | Xn; N R: 22-51/53 S: (2-)25-61 | |
602-107-00-3 | 3,3,4,4-tetrafluoro-4-iodo-1-butene | | 439-500-2 | 33831-83-3 | Xn; R22 Xi; R38 N; R51-53 | Xn; N R: 22-38-51/53 S: (2-)37-61 | |
602-108-00-9 | (2,3,5,6-tetrafluorophenyl)methanol | | 443-840-7 | 4084-38-2 | Xn; R22 Xi; R36 R43 | Xn R: 22-36-43 S: (2-)26-36/37 | |
603-211-00-1 | 2,3-epoxypropyltrimethylammonium chloride … %; glycidyl trimethylammonium chloride … % | B E | 221-221-0 | 3033-77-0 | Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 Xn; R21/22-48/22 Xi; R41 R43 R52-53 | T R: 45-21/22-41-43-48/22-62-68-52/53 S: 53-45-61 | |
603-212-00-7 | 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran; galaxolide; (HHCB) | | 214-946-9 | 1222-05-5 | N; R50-53 | N R: 50/53 S: 60-61 | |
603-213-00-2 | 2-methoxy-2-methylbutane; tert-amyl methyl ether | | 213-611-4 | 994-05-8 | F; R11 Xn; R22 R67 | F; Xn R: 11-22-67 S: (2-)9-16-23-33 | |
603-214-00-8 | 1,1-diisopropoxycyclohexane | | 413-740-8 | 1132-95-2 | C; R34 | C R: 34 S: (1/2-)23-26-36/37/39-45 | |
603-215-00-3 | 1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) | | 418-330-2 | 162241-33-0 | E; R2 Xn; R22-48/22 Xi; R41 R43 N; R50-53 | E; Xn; N R: 2-22-41-43-48/22-50/53 S: (2-)22-26-36/37/39-60-61 | |
603-216-00-9 | cis-1-amino-2,3-dihydro-1H-inden-2-ol | | 422-660-2 | 7480-35-5 | Xi; R41 R43 R52-53 | Xi R: 41-43-52/53 S: (2-)24-26-37/39-61 | |
603-217-00-4 | 2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite | | 423-560-1 | 161717-32-4 | R43 R53 | Xi R: 43-53 S: (2-)24-37/39-61 | |
603-220-00-0 | 1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol | | 432-890-5 | 72955-94-3 | R53 | R: 53 S: 61 | |
603-221-00-6 | 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing < 0,1 % 4-chloroaniline (EC No 203-401-0)] | | 433-580-2 | 214353-17-0 | Xn; R22 C; R34 N; R51-53 | C; N R: 22-34-51/53 S: (1/2-)26-36/37/39-45-61 | |
603-221-01-3 | 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride; [containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)] | E | 433-580-2 | 214353-17-0 | Carc. Cat. 2; R45 Xn; R22 C; R34 N; R51-53 | T; N R: 45-22-34-51/53 S: 53-45-61 | |
603-222-00-1 | (2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane | | 433-820-6 | 118058-74-5 | Xi; R36 | Xi R: 36 S: (2-)26 | |
603-223-00-7 | 2-cyclopentylidene cyclopentanol; 1,1′-bi(cyclopentyliden)-2-ol | | 434-270-1 | 6261-30-9 | Xi; R38-41 R52-53 | Xi R: 38-41-52/53 S: (2-)26-37/39-61 | |
603-224-00-2 | 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane | | 435-790-1 | 297730-93-9 | R53 | R: 53 S: 61 | |
603-225-00-8 | erythromycin A9-oxime (E); (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E) | | 437-070-0 | 13127-18-9 | N; R51-53 | N R: 51/53 S: 61 | |
603-226-00-3 | 4,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol | | 444-500-0 | 1440-00-2 | R52-53 | R: 52/53 S: 61 | |
603-227-00-9 | α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1); reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate | | 445-060-2 | 203574-04-3 | O; R7 N; R50-53 | O; N R: 7-50/53 S: (2-)3/7-14-36/37/39-60-61 | |
603-228-00-4 | (+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran; 6-fluoro-2-(2-oxiranyl)chromane | | 419-620-1 | — | R43 N; R51-53 | Xi; N R: 43-51/53 S: (2-)36/37-61 | |
603-229-00-X | sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate | | 420-800-7 | — | Xi; R38-41 R43 N; R50-53 | Xi; N R: 38-41-43-50/53 S: (2-)24-26-37/39-60-61 | |
603-230-00-5 | 2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan | | 440-030-5 | — | Xi; R38-41 R53 | Xi R: 38-41-53 S: (2-)26-37/39-61 | |
603-231-00-0 | (S)-1,1-diphenyl-1,2-propanediol | | 443-220-6 | — | R52-53 | R: 52/53 S: 22-61 | |
603-232-00-6 | 3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane | | 444-420-6 | — | R53 | R: 53 S: 61 | |
603-233-00-1 | mixture of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol; 1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; 1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol; (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol | | 444-430-0 | — | N; R51-53 | N R: 51/53 S: 61 | |
603-234-00-7 | (1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene | | 444-480-3 | — | Xi; R38 N; R51-53 | Xi; N R: 38-51/53 S: (2-)37-61 | |
604-074-00-0 | tetrabromobisphenol-A; 2,2′,6,6′-tetrabromo-4,4′-isopropylidenediphenol | | 201-236-9 | 79-94-7 | N; R50-53 | N R: 50/53 S: 60-61 | |
604-075-00-6 | 4-(1,1,3,3-tetramethylbutyl)phenol; 4-tert-octylphenol | | 205-426-2 | 140-66-9 | Xi; R38-41 N; R50-53 | Xi; N R: 38-41-50/53 S: (2-)26-37/39-60-61 | C ≥ 20 %: Xi, N; R38-41-50/53 10 % ≤ C < 20 %: Xi, N; R41-50/53 5 % ≤ C < 10 %: Xi, N; R36-50/53 2,5 % ≤ C < 5 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
604-076-00-1 | phenolphthalein | | 201-004-7 | 77-09-8 | Carc. Cat. 2; R45 Muta. Cat. 3; R68 Repr. Cat. 3; R62 | T R: 45-62-68 S: 53-45 | C ≥ 5 %: T; R45-62-68 1 % ≤ C < 5 %: T; R45-68 |
604-077-00-7 | 2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol | | 419-750-9 | 98809-58-6 | R53 | R: 53 S: 61 | |
604-079-00-8 | 4,4′-(1,3-phenylene-bis(1-methylethylidene))bis-phenol | | 428-970-4 | 13595-25-0 | Repr.Cat.3; R62 R43 N; R51-53 | Xn; N R: 43-62-51/53 S: (2-)22-36/37-61 | |
604-080-00-3 | 4-fluoro-3-trifluoromethylphenol | | 432-560-0 | 61721-07-1 | Xn; R20 C; R35 R43 N; R51-53 | C; N R: 20-35-43-51/53 S: (1/2-)26-28-36/37/39-45-61 | |
604-081-00-9 | 1,1-bis(4-hydroxyphenyl)-1-phenylethane | | 433-130-5 | 1571-75-1 | N; R50-53 | N R: 50/53 S: 25-60-61 | |
604-082-00-4 | 2-chloro-6-fluoro-phenol | E | 433-890-8 | 2040-90-6 | Muta.Cat.2; R46 Repr.Cat.3; R62 Xn; R22 C; R34 R43 N; R51-53 | T; N R: 46-22-34-43-62-51/53 S: 53-45-61 | |
604-083-00-X | 4,4′-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol | | 439-270-3 | 260408-02-4 | R53 | R: 53 S: 61 | |
604-084-00-5 | 1-ethoxy-2,3-difluorobenzene | | 441-000-4 | 121219-07-6 | Xn; R22 R52-53 | Xn R: 22-52/53 S: (2-)23-61 | |
604-087-00-1 | mixture of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol; 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol | | 433-640-8 | — | F; R17 R44 R53 | F R: 17-44-53 S: (2-)15-22-61 | |
604-089-00-2 | 2-methyl-5-tert-butylthiophenol | | 444-970-7 | — | R10 Repr.Cat.3; R63 Xn; R48/20/22-65 Xi; R36/38 R43 R67 N; R50-53 | Xn; N R: 10-36/38-43-48/20/22-63-65-67-50/53 S: (2-)26-36/37-62-60-61 | |
605-037-00-1 | trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde; 3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde | | 421-800-1 | 120578-03-2 | R53 | R: 53 S: 22-61 | |
605-038-00-7 | 3-methyl-5-phenylpentan-1-al | | 433-900-0 | 55066-49-4 | Xn; R22 Xi; R38 R43 N; R51-53 | Xn; N R: 22-38-43-51/53 S: (2-)36/37-61 | |
605-039-00-2 | 3,4-dihydroxy-5-nitrobenzaldehyde | | 441-810-8 | 116313-85-0 | Xn; R22 Xi; R41 R43 | Xn R: 22-41-43 S: (2-)22-24-26-37/39 | |
606-124-00-7 | 1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione | | 421-080-7 | 161462-35-7 | Xn; R48/22 N; R50-53 | Xn; N R: 48/22-50/53 S: (2-)36-60-61 | |
606-125-00-2 | 1-benzylimidazolidine-2,4-dione | | 421-340-1 | 6777-05-5 | Xn; R22 | Xn R: 22 S: (2-)22 | |
606-126-00-8 | 1,4-bis(2,3-dihydroxypropylamino)anthraquinone | | 421-470-7 | 99788-75-7 | N; R51-53 | N R: 51/53 S: 61 | |
606-128-00-9 | 2,2′-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione | | 422-650-8 | 148935-94-8 | R53 | R: 53 S: 61 | |
606-129-00-4 | 5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one; (2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one | | 423-090-7 | 156732-13-7 | R53 | R: 53 S: 61 | |
606-130-00-X | 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone | | 423-860-2 | 56309-94-5 | R43 R52-53 | Xi R: 43-52/53 S: (2-)24-37-61 | |
606-131-00-5 | cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione | E | 427-230-8 | 5571-36-8 | Repr. Cat. 2; R60 Xn; R48/22 N; R51-53 | T; N R: 60-48/22-51/53 S: 53-45-61 | |
606-132-00-0 | (6β)-6,19-epoxyandrost-4-ene-3,17-dione | | 433-490-3 | 6563-83-3 | R43 R52-53 | Xi R: 43-52/53 S: (2-)24-37-61 | |
606-134-00-1 | androsta-1,4,9(11)-triene-3,17-dione | | 433-560-3 | 15375-21-0 | Repr. Cat.3; R62 | Xn R: 62 S: (2-)22-36/37 | |
606-135-00-7 | cyclohexadecanone | | 438-930-8 | 2550-52-9 | R53 | R: 53 S: 61 | |
606-136-00-2 | (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone | | 444-350-6 | 133413-70-4 | Xi; R36 R53 | Xi R: 36-53 S: (2-)26-61 | |
606-137-00-8 | trans-7,7′-dimethyl-(4H,4 H′)-(2,2′)bi[benzo[1,4]thiazinylidene]-3,3′-dione | | 444-750-0 | 211387-26-7 | R53 | R: 53 S: 22-61 | |
606-138-00-3 | (2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone | | 444-800-1 | 141645-23-0 | R10 Xn; R22-48/22 Xi; R38-41 R43 N; R50-53 | Xn; N R: 10-22-38-41-43-48/22-50/53 S: (2-)23-26-36/37/39-60-61 | C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/53 20 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/53 10 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/53 5 % ≤ C < 10 %: Xi, N; R36-43-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
606-139-00-9 | (S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one | | 444-830-5 | 124379-29-9 | R53 | R: 53 S: 61 | |
606-140-00-4 | 2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one | | 444-860-9 | 474510-57-1 | Xn; R48/22 N; R50-53 | Xn; N R: 48/22-50/53 S: (2-)22-36-60-61 | |
606-141-00-X | sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate | | 418-410-7 | — | Xi; R36 | Xi R: 36 S: (2-)26 | |
606-142-00-5 | mixture of: (1 RS,2 SR,7 SR,8 SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1 RS,2 SR,7 SR,8 SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1 RS,2 SR,7 SR,8 SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one | | 434-290-9 | — | Xn; R22 N; R51-53 | Xn; N R: 22-51/53 S: (2-)61 | |
607-580-00-X | ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate | | 422-360-1 | 100491-29-0 | R43 N; R51-53 | Xi; N R: 43-51/53 S: (2-)22-24-37-61 | |
607-618-00-5 | menadione sodium bisulfite; 2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt | | 204-987-0 | 130-37-0 | Xi; R36/38 N; R50-53 | Xi; N R: 36/38-50/53 S: (2-)24/25-60-61 | |
607-619-00-0 | menadione nicotinamide bisulfite; 1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1) | | 277-543-7 | 73581-79-0 | Xi; R36/38 N; R50-53 | Xi; N R: 36/38-50/53 S: (2-)24/25-60-61 | |
607-620-00-6 | trisodium nitrilotriacetate | | 225-768-6 | 5064-31-3 | Carc. Cat. 3; R40 Xn; R22 Xi; R36 | Xn R: 22-36-40 S: (2-)26-36/37-46 | C ≥ 25 %: Xn; R22-36-40 20 ≤ % C < 25 %: Xn; R36-40 5 ≤ % C < 20 %: Xn; R40 |
607-621-00-1 | milbemectin (ISO); [mixture of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)] | | — | — | Xn; R20/22 N; R50-53 | Xn; N R: 20/22-50/53 S: (2-)46-60-61 | C ≥ 25 %: Xn, N; R20/22-50/53 0,25 % ≤ C < 25 %: N; R50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 % ≤ C < 0,025 %: R52/53 |
607-622-00-7 | 2-ethylhexyl-2-ethylhexanoate | | 231-057-1 | 7425-14-1 | Repr. Cat. 3; R63 | Xn R: 63 S: (2-)36/37 | |
607-623-00-2 | diisobutyl phthalate | | 201-553-2 | 84-69-5 | Repr. Cat. 2; R61 Repr. Cat. 3; R62 | T R: 61-62 S: 53-45 | C ≥ 25 %: T; R61-62 5 % ≤ C < 25 %: Xn; R62 |
607-624-00-8 | perfluorooctane sulfonic acid; heptadecafluorooctane-1-sulfonic acid; [1] potassium perfluorooctanesulfonate; potassium heptadecafluorooctane-1-sulfonate; [2] diethanolamine perfluorooctane sulfonate; [3] ammonium perfluorooctane sulfonate; ammonium heptadecafluorooctanesulfonate; [4] lithium perfluorooctane sulfonate; lithium heptadecafluorooctanesulfonate [5] | E | 217-179-8 [1] 220-527-1 [2] 274-460-8 [3] 249-415-0 [4] 249-644-6 [5] | 1763-23-1 [1] 2795-39-3 [2] 70225-14-8 [3] 29081-56-9 [4] 29457-72-5 [5] | Carc. Cat. 3; R40 Repr. Cat. 2; R61 T; R48/25 Xn; R20/22 R64 N; R51-53 | T; N R: 61-20/22-40-48/25-64-51/53 S: 53-45-61 | |
607-625-00-3 | clodinafop-propargyl (ISO) | | — | 105512-06-9 | Xn; R22-48/22 R43 N; R50-53. | Xn; N R: 22-43-48/22-50/53 S: (2-)24-36/37-46-60-61 | C ≥ 25 %: Xn, N; R22-43-48/22-50/53 10 % ≤ C < 25 %: Xn, N; R43-48/22-51/53 2,5 % ≤ C < 10 %: Xi, N; R43-51/53 0,25 % ≤ C < 2,5 %: Xi; R43-52/53 0,001 % ≤ C < 0,25 %: Xi; R43 |
607-626-00-9 | ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate | | 401-290-5 | 103112-35-2 | Carc.Cat.2; R45 N; R50-53 | T; N R: 45-50/53 S: 53-45-60-61 | |
607-627-00-4 | [(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate | | 416-360-0 | 162221-28-5 | R43 | Xi R: 43 S: (2-)22-24-37 | |
607-628-00-X | 4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine | | 419-240-6 | 171054-89-0 | Xi; R41 | Xi R: 41 S: (2-)26-39 | |
607-629-00-5 | [[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid | | 419-270-1 | 123599-82-6 | Xi; R36 | Xi R: 36 S: (2-)26 | |
607-630-00-0 | acrylic acid, 3-(trimethoxysilyl)propyl ester | | 419-560-6 | 4369-14-6 | Xn; R20 C; R34 R43 R52-53 | C R: 20-34-43-52/53 S: (1/2-)26-36/37/39-45-61 | |
607-631-00-6 | mixture of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate; (2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate | | 442-300-8 | — | R43 | Xi R: 43 S: (2-)24-37 | |
607-632-00-1 | N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide | | 420-210-1 | 111244-14-5 | R53 | R: 53 S: 61 | |
607-633-00-7 | trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate | | 440-480-2 | 341026-59-3 | Xi; R41 R43 | Xi R: 41-43 S: (2-)22-24-26-37/39 | |
607-634-00-2 | (S)-(-)-2-acetoxypropionylchloride; (1S)-2-chloro-1-methyl-2-oxoethyl acetate | | 420-610-4 | 36394-75-9 | Xn; R22 C; R34 R43 | C R: 22-34-43 S: (1/2-)23-26-36/37/39-45 | |
607-635-00-8 | trisodium N-(3-propionato)-L-aspartate | | 422-090-4 | 172737-80-3 | Xi; R41 | Xi R: 41 S: (2-)26-39 | |
607-636-00-3 | 1-bromo-2-methylpropyl propionate | | 422-900-6 | 158894-67-8 | R10 Carc.Cat.3; R40 C; R34 R43 | C R: 10-34-40-43 S: (1/2-)7/9-8-23-26-36/37/39-45 | |
607-637-00-9 | disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate | | 423-730-5 | 250688-43-8 | Xi; R41 | Xi R: 41 S: (2-)26-39 | |
607-638-00-4 | 2-hydroxybenzoic acid 2-butyloctyl ester | | 431-090-3 | 190085-41-7 | R53 | R: 53 S: 61 | |
607-639-00-X | 2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate | | 431-770-1 | 216698-07-6 | R53 | R: 53 S: 61 | |
607-641-00-0 | 2-(formylamino)-3-thiophenecarboxylic acid; 2-formamido-3-thiophenecarboxylic acid | | 431-930-9 | 43028-69-9 | Xn; R22 R43 | Xn R: 22-43 S: (2-)22-24-37 | |
607-642-00-6 | 3,6,9-trithiaundecamethylene-1,11-dimethacrylate | | 432-210-7 | 141631-22-3 | N; R50-53 | N R: 50/53 S: 60-61 | |
607-643-00-1 | dimethyl (2S)-2-hydroxysuccinate | | 432-310-0 | 617-55-0 | R10 Xi; R41 R43 | Xi R: 10-41-43 S: (2-)24-26-37/39-43 | |
607-644-00-7 | methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate | | 432-350-9 | 81752-87-6 | Xi; R38 | Xi R: 38 S: (2-)37 | |
607-645-00-2 | tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate | | 432-550-6 | 243858-01-7 | Xi; R41 | Xi R: 41 S: (2-)22-26-39 | |
607-646-00-8 | D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester; tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate | | 432-960-5 | 124655-09-0 | Xn; R22 | Xn R: 22 S: (2-)25 | |
607-647-00-3 | 5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane | | 433-530-1 | 143446-73-5 | Xn; R22 R43 N; R50 | Xn; N R: 22-43-50 S: (2-)24-37-57-61 | |
607-649-00-4 | [3-(chlorocarbonyl)-2-methylphenyl]acetate | | 433-690-0 | 167678-46-8 | C; R35 R43 | C R: 35-43 S: (1/2-)7/8-26-36/37/39-45 | |
607-650-00-X | 2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate | | 433-910-5 | 145153-52-2 | R43 | Xi R: 43 S: (2-)24-37 | |
607-651-00-5 | sodium 2-(nonanoyloxy)benzenesulfonate | | 434-360-9 | 91125-43-8 | Xi; R41 R43 | Xi R: 41-43 S: (2-)24-26-37/39 | |
607-652-00-0 | ethyl N 2-dodecanoyl-L-argininate hydrochloride | | 434-630-6 | 60372-77-2 | Xi; R41 N; R50 | Xi; N R: 41-50 S: (2-)26-39-61 | |
607-653-00-6 | tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate | | 434-840-8 | 225786-91-4 | N; R51-53 | N R: 51/53 S: 61 | |
607-654-00-1 | (S)-3-hydroxy-γ-butyrolactone | | 434-990-4 | 7331-52-4 | R43 | Xi R: 43 S: (2-)23-24-37 | |
607-655-00-7 | ethyl 6,8-dichlorooctanoate | | 435-080-1 | 1070-64-0 | R43 N; R51-53 | Xi; N R: 43-51/53 S: (2-)24-37-61 | |
607-656-00-2 | sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid | | 435-350-7 | 141250-43-3 | Xi; R41 R52-53 | Xi R: 41-52/53 S: (2-)22-26-39-61 | |
607-657-00-8 | pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate | | 436-920-8 | 172399-10-9 | Xi; R41 | Xi R: 41 S: (2-)22-26-39 | |
607-658-00-3 | 3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt | | 440-770-9 | 371921-63-0 | Xi; R41 R52-53 | Xi R: 41-52/53 S: (2-)26-39-61 | |
607-659-00-9 | pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid | | 442-030-0 | 321912-47-4 | Xi; R41 | Xi R: 41 S: (2-)22-26-39 | |
607-660-00-4 | 2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt | | 442-230-8 | 321679-52-1 | Xi; R41 | Xi R: 41 S: (2-)22-26-39 | |
607-661-00-X | 1,1-dimethylethyl 4′-(bromomethyl)biphenyl-2-carboxylate | | 442-850-9 | 114772-40-6 | R43 R53 | Xi R: 43-53 S: (2-)22-24-37-61 | |
607-662-00-5 | methyl 2-(acetylamino)-3-chloropropionate | | 442-860-3 | 87333-22-0 | R43 N; R50-53 | Xi; N R: 43-50/53 S: (2-)24-37-60-61 | |
607-663-00-0 | bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate | | 442-980-6 | 127474-91-3 | R53 | R: 53 S: 61 | |
607-664-00-6 | methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate | | 443-120-2 | 393509-79-0 | Xi; R41 N; R51-53 | Xi; N R: 41-51/53 S: (2-)26-39-61 | |
607-665-00-1 | trans-methyl-2-ethyl-but-2-enoate | | 443-150-6 | 101226-85-1 | R10 | R: 10 S: 23 | |
607-666-00-7 | (2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid | | 443-560-5 | 88784-33-2 | Xi; R36 | Xi R: 36 S: (2-)26 | |
607-667-00-2 | chloro-1-ethylcyclohexyl carbonate | | 444-950-8 | 99464-83-2 | Muta.Cat.3; R68 R43 | Xn R: 43-68 S: (2-)23-36/37 | |
607-668-00-8 | trans-2-isopropyl-5-carboxy-1,3-dioxane | | 445-770-2 | 42031-28-7 | Xi; R41 R52-53 | Xi R: 41-52/53 S: (2-)22-26-39-61 | |
607-669-00-3 | methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate | | 445-990-9 | 376588-17-9 | R43 R53 | Xi R: 43-53 S: (2-)24-37-61 | |
607-670-00-9 | dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate | | 448-700-9 | 500791-70-8 | Xn; R48/22 Xi; R41 R43 N; R50-53 | Xn; N R: 41-43-48/22-50/53 S: (2-)22-26-36/37/39-60-61 | C ≥ 10 %: Xn, N; R41-43-48/22-50/53 5 % ≤ C < 10 %: Xi, N; R36-43-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
607-671-00-4 | diethyl 1,4-cyclohexanedicarboxylate | | 417-310-0 | 72903-27-6 | N; R51-53 | N R: 51/53 S: 61 | |
607-672-00-X | mixture of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate; 1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate; x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate | | 419-000-0 | — | R43 N; R51-53 | Xi; N R: 43-51/53 S: (2-)24-37-61 | |
607-673-00-5 | 1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate | | 419-570-0 | — | Xn; R22 R52-53 | Xn R: 22-52/53 S: (2-)61 | |
607-674-00-0 | branched C 10-alkyl benzoates | | 421-090-1 | 131298-44-7 | Xn; R20 | Xn R: 20 S: (2-)23 | |
607-675-00-6 | mixture of: cis-9-octadecenedioic acid; cis-9-cis-12-octadecadienedioic acid; hexadecanedioic acid; octadecanedioic acid | | 422-260-8 | — | Xi; R41 N; R50-53 | Xi; N R: 41-50/53 S: (2-)26-39-60-61 | |
607-676-00-1 | mixture of: 2-methylnonanedioic acid; 2,4-dimethyl-4-methoxycarbonylundecanedioic acid; 2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid; 8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid | | 423-670-1 | — | Xi; R41 R43 | Xi R: 41-43 S: (2-)24-26-37/39 | |
607-677-00-7 | 2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinate | | 424-660-8 | — | Xn; R48/22 Xi; R41 R43 | Xn R: 41-43-48/22 S: (2-)22-26-36/37/39 | |
607-678-00-2 | mixture of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate; ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate | | 427-090-8 | — | R43 N; R51-53 | Xi; N R: 43-51/53 S: (2-)23-25-36/37-61 | |
607-679-00-8 | mixture of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate); 3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate); 3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate) | | 431-440-5 | — | Xi; R41 N; R51-53 | Xi; N R: 41-51/53 S: (2-)22-26-39-61 | |
607-680-00-3 | tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate | | 432-810-9 | — | R53 | R: 53 S: 61 | |
607-681-00-9 | mixture of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid; 9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid; dihexadecyl 9-nonyl-10-octylnonadecandioate; 1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate; dioctadecyl 9-nonyl-10-octylnonadecandioate | | 432-910-2 | — | R53 | R: 53 S: 61 | |
607-682-00-4 | complex mixture of Chinese gum rosin post reacted with acrylic acid | | 434-230-1 | 144413-22-9 | R53 | R: 53 S: 61 | |
607-683-00-X | mixture of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate; methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80) | | 435-450-0 | — | R43 N; R51-53 | Xi; N R: 43-51/53 S: (2-)24-37-61 | |
607-684-00-5 | alkenes, C 12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts | | 435-660-2 | 243662-67-1 | Xi; R38 R43 | Xi R: 38-43 S: (2-)24-37 | |
607-685-00-0 | ammonium 2-cocoyloxyethanesulfonate | | 441-050-7 | — | Xi; R38-41 | Xi R: 38-41 S: (2-)26-37/39 | |
607-686-00-6 | 6,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate) | | 441-550-5 | — | E; R2 F; R11 Carc. Cat. 3; R40 | E; Xn R: 2-11-40 S: (2-)7-22-36/37 | |
607-687-00-1 | mixture of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %); 2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %) | | 442-800-6 | — | Xi; R38 N; R51-53 | Xi; N R: 38-51/53 S: (2-)37-61 | |
607-688-00-7 | (R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride | | 444-320-2 | — | Xn; R22 | Xn R: 22 S: (2-) | |
607-689-00-2 | mixture of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including cis- and trans- isomers); methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’ including cis- and trans-isomers) | | 444-920-4 | — | R52-53 | R: 52/53 S: 61 | |
607-690-00-8 | dimethyl[2S,2 S′]-6,6,6′6′-tetramethoxy-2,2′-[N,N′-bis(trifluoracetyl)-S,S′-bi(L-homocysteinyl) diimino]dihexanoate | | 432-860-1 | 255387-46-3 | R43 | Xi R: 43 S: (2-)24-37 | |
607-691-00-3 | magnesium salts, fatty acids, C 16-18 and C 18 unsaturated, branched and linear | | 448-690-6 | — | R53 | R: 53 S: 61 | |
607-692-00-9 | zinc salts, fatty acids, C 16-18 and C 18 unsaturated, branched and linear | | 446-470-4 | — | R53 | R: 53 S: 61 | |
607-693-00-4 | hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate | | 443-860-6 | 302776-68-7 | R53 | R: 53 S: 61 | |
607-694-00-X | ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate | | 443-870-0 | 163520-33-0 | Xn; R22 R43 N; R50-53 | Xn; N R: 22-43-50/53 S: (2-)22-36/37-60-61 | |
608-042-00-7 | (S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide | | 421-810-4 | 194602-27-2 | Xn; R22 Xi; R41 R43 N; R51-53 | Xn; N R: 22-41-43-51/53 S: (2-)24-26-37/39-61 | |
608-059-00-X | 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile | | 421-240-6 | 120068-79-3 | N; R51-53 | N R: 51/53 S: 22-61 | |
608-060-00-5 | 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile | | 421-300-1 | 138564-59-7 | N; R50-53 | N R: 50/53 S: 22-60-61 | |
608-062-00-6 | 2-fluoro-4-hydroxybenzonitrile | | 422-810-7 | 82380-18-5 | Xn; R22 Xi; R41 N; R51-53 | Xn; N R: 22-41-51/53 S: (2-)22-26-39-61 | |
608-063-00-1 | (S)-α-hydroxy-3-phenoxy-benzeneacetonitrile | | 441-070-6 | 61826-76-4 | T; R25 Xi; R41 R43 N; R50-53 | T; N R: 25-41-43-50/53 S: (1/2-)9-26-36/37/39-45-60-61 | |
608-064-00-7 | cyanomethyltrimethylammoniummethylsulfate | | 433-720-2 | — | R52-53 | R: 52/53 S: 61 | |
609-069-00-7 | musk ketone; 3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone; 4′-tert-butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenone | | 201-328-9 | 81-14-1 | Carc. Cat. 3; R40 N; R50-53 | Xn; N R: 40-50/53 S: (2-)36/37-46-60-61 | |
611-154-00-9 | trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate | | 403-670-6 | 92408-46-3 | R52-53 | R: 52/53 S: 61 | |
611-155-00-4 | 4,4′-oxybis(benzenesulfonylazide) | | 431-850-4 | 7456-68-0 | E; R3 F; R11 Xn; R48/22 N; R50-53 | E; Xn; N R: 3-11-48/22-50/53 S: (2-)14-22-33-35-36-60-61 | |
611-156-00-X | triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate | | 432-270-4 | 221354-37-6 | Repr. Cat. 3; R62 Xn; R48/22 N; R51-53 | Xn; N R: 48/22-62-51/53 S: (2-)36/37-61 | |
611-157-00-5 | benzenesulfonic acid, 3,3′-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt; potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate | | 432-590-4 | 243869-48-9 | Xi; R36 R52-53 | Xi R: 36-52/53 S: (2-)26-61 | |
611-158-00-0 | reaction mixture of: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride | | 421-520-8 | — | F; R11 R53 | F R: 11-53 S: (2-)3-12-16-33-61 | |
611-159-00-6 | disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate | | 421-880-6 | — | Xi; R41 R52-53 | Xi R: 41-52/53 S: (2-)26-39-61 | |
611-160-00-1 | mixture of: 1,1,1-tris(phenyl-4′-(3″-diazo-3″,4″-dihydro-4″-oxo-naphthalene-1″-sulfonato)ethane; 1,1,1-tris(phenyl-4′-(6″-diazo-5″,6″-dihydro-5″-oxo-naphthalene-1″-sulfonato)ethane; reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1); reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2) | | 422-760-6 | — | F; R11 R53 | F R: 11-53 S: (2-)3-12-33-61 | |
611-161-00-7 | trisodium [1,2′-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4′-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III) | | 423-100-1 | — | Xi; R41 | Xi R: 41 S: (2-)26-39 | |
611-162-00-2 | 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate) | | 429-600-4 | — | Xn; R22 Xi; R41 N; R51-53 | Xn; N R: 22-41-51/53 S: (2-)22-26-39-61 | |
611-163-00-8 | 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate | | 429-610-9 | — | Xn; R22 Xi; R41 N; R51-53 | Xn; N R: 22-41-51/53 S: (2-)22-26-39-61 | |
611-164-00-3 | mixture of: 2,2′-dimethyl-2,2′-azobutanenitrile; 2-methylpentanenitrile-2-azo-2′-(2′-methylpropanenitrile); 2,2′-dimethyl-2,2′-azoheptanenitrile; 2-methylheptanenitrile-2-azo-2′-(2′-methylpropanenitrile); 2-methylheptanenitrile-2-azo-2′-(2′-methylbutanenitrile) | | 429-710-2 | — | R10 R32 R44 Xn; R22 N; R51-53 | Xn; N R: 10-22-32-44-51/53 S: (2-)12-15-16-47-51-61 | |
611-165-00-9 | mixture of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate; tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate | | 431-830-5 | — | R52-53 | R: 52/53 S: 61 | |
611-166-00-4 | mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate | | 432-100-9 | — | Xi; R41 R52-53 | Xi R: 41-52/53 S: (2-)26-39-61 | |
611-167-00-X | sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cuprate(II) | | 435-240-9 | — | R52-53 | R: 52/53 S: 61 | |
611-168-00-5 | mixture of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid; 3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid | | 435-440-6 | — | Xi; R41 | Xi R: 41 S: (2-)22-26-39 | |
611-169-00-0 | sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate | | 435-800-2 | — | R52-53 | R: 52/53 S: 61 | |
611-170-00-6 | mixture of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N 2)-1-phenylmethyl)azo-κ-N 1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II); disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N 2)-1-phenylmethyl)azo-κ-N 1)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II) | | 435-880-9 | — | R52-53 | R: 52/53 S: 22-61 | |
611-171-00-1 | mixture of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate; trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate | | 436-890-6 | — | Xi; R41 R52-53 | Xi R: 41-52/53 S: (2-)22-26-39-61 | |
611-172-00-7 | mixture of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate | | 438-310-7 | — | E; R2 Repr. Cat. 3; R62 Xn; R22-48/22 R52-53 | E; Xn R: 2-22-48/22-62-52/53 S: (2-)22-35-36/37-61 | |
611-173-00-2 | mixture of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt; 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt | | 440-510-4 | — | Xi; R41 R43 | Xi R: 41-43 S: (2-)22-26-36/37/39 | |
611-174-00-8 | mixture of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt; 3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt | | 442-290-5 | 457624-86-1 | Xi; R41 | Xi R: 41 S: (2-)22-26-39 | |
611-175-00-3 | mixture of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate | | 444-050-5 | — | Xi; R41 R52-53 | Xi R: 41-52/53 S: (2-)22-26-39-61 | |
611-176-00-9 | 2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate | | 444-250-2 | — | E; R2 F; R11 N; R51-53 | E; N R: 2-11-51/53 S: (2-)22-61 | |
611-177-00-4 | mixture of: pentasodium bis[6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III); tetrasodium [6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III); trisodium bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III) | | 444-290-0 | 508202-43-5 | Xi; R41 R43 R52-53 | Xi R: 41-43-52/53 S: (2-)22-24-26-37/39-61 | |
611-178-00-X | mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate; trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate | | 445-280-9 | — | Xi; R41 R43 R52-53 | Xi R: 41-43-52/53 S: (2-)24-26-37/39-61 | |
611-179-00-5 | mixture of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate; 2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate | | 450-010-8 | — | Xi; R41 R43 | Xi R: 41-43 S: (2-)22-24-26-37/39 | |
611-180-00-0 | iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts | | 417-850-7 | — | N; R51-53 | N R: 51/53 S: 22-61 | |
612-238-00-8 | (3-chloro-2-hydroxypropyl) trimethylammonium chloride … % | B | 222-048-3 | 3327-22-8 | Carc. Cat. 3, R40 R52-53 | Xn R: 40-52/53 S: 36/37-61 | |
612-239-00-3 | biphenyl-3,3′,4,4′-tetrayltetraamine; diaminobenzidine | | 202-110-6 | 91-95-2 | Carc. Cat. 2; R45 Muta. Cat. 3; R68 | T R: 45-68 S: 53-45 | |
612-240-00-9 | pyrimethanil (ISO); N-(4,6-dimethylpyrimidin-2-yl)aniline | | — | 53112-28-0 | N; R51-53 | N R: 51/53 S: 61 | |
612-241-00-4 | piperazine hydrochloride; [1] piperazine dihydrochloride; [2] piperazine phosphate [3] | | 228-042-7 [1] 205-551-2 [2] 217-775-8 [3] | 6094-40-2 [1] 142-64-3 [2] 1951-97-9 [3] | Repr. Cat. 3; R62-63 Xi; R36/38 R42/43 R52-53 | Xn R: 36/38-42/43-62-63-52/53 S: (1/2-)22-36/37-45-63-61 | |
612-242-00-X | cyprodinil (ISO); 4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine | | — | 121552-61-2 | R43 N; R50-53 | Xi; N R: 43-50/53 S: (2-)24-37-46-60-61 | C ≥ 2,5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
612-243-00-5 | (1 S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate | | 420-560-3 | 79617-97-3 | Xi; R41 N; R50-53 | Xi; N R: 41-50/53 S: (2-)26-39-60-61 | C ≥ 10 %: Xi, N; R41-50/53 5 % ≤ C < 10 %: Xi, N; R36-50/53 2,5 % ≤ C < 5 %: N; R50/53 0,25 % ≤ C < 2, 5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
612-244-00-0 | 3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride | | 421-310-6 | 87691-88-1 | Repr. Cat. 3; R62 Xn; R22 Xi; R36 R43 N; R50-53 | Xn; N R: 22-36-43-62-50/53 S: (2-)22-26-36/37/39-60-61 | |
612-245-00-6 | 2-ethylphenylhydrazine hydrochloride | | 421-460-2 | 19398-06-2 | Carc. Cat. 3; R40 T; R48/25 Xn; R22 Xi; R41 R43 N; R50-53 | T; N R: 22-40-41-43-48/25-50/53 S: (1/2-)22-26-36/37/39-45-60-61 | C ≥ 25 %: T, N; R22-40-41-43-48/25-50/53 10 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/53 5 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/53 2,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/53 1 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
612-246-00-1 | (2-chloroethyl)(3-hydroxypropyl)ammonium chloride | E | 429-740-6 | 40722-80-3 | Carc. Cat. 2; R45 Muta. Cat. 2; R46 Xn; R48/22 R43 R52-53 | T R: 45-46-43-48/22-52/53 S: 53-45-61 | |
612-247-00-7 | N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N′-hydroxy-4-nitrobenzenecarboximidamide | | 423-530-8 | 152828-23-4 | T; R48/25 Xn; R22 R52-53 | T R: 22-48/25-52/53 S: (1/2-)22-36-45-61 | |
612-248-00-2 | reaction product of diphenylamine, phenothiazine, and alkenes, branched (C 8-10, C9-rich) | | 439-540-0 | — | Xi; R38 R43 R53 | Xi R: 38-43-53 S: (2-)24-37-61 | |
612-249-00-8 | 4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride | | 425-030-5 | 159939-85-2 | Repr. Cat. 3; R62 Xn; R22 C; R34 R43 N; R51-53 | C; N R: 22-34-43-62-51/53 S: (1/2-)22-26-36/37/39-45-61 | |
612-250-00-3 | chloro-N,N-dimethylformiminium chloride | E | 425-970-6 | 3724-43-4 | R14 Repr. Cat. 2; R61 Xn; R22 C; R35 | T; C R: 61-14-22-35 S: 53-45 | |
612-251-00-9 | cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride | | 426-020-3 | 51229-78-8 | F; R11 Repr. Cat. 3; R63 Xn; R22 Xi; R38 R43 N; R51-53 | F; Xn; N R: 11-22-38-43-63-51/53 S: (2-)7-22-33-36/37-61 | |
612-252-00-4 | imidacloprid (ISO); 1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine | | 428-040-8 | 138261-41-3 | Xn; R22 N; R50-53 | Xn; N R: 22-50/53 S: (2-)22-57-60-61 | |
612-253-00-X | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing < 0,5 % formamide (EC No 200-842-0)] | | 429-400-7 | 199327-61-2 | R52-53 | R: R52/53 S: 61 | |
612-253-01-7 | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one; [containing ≥ 0,5 % formamide (EC No 200-842-0)] | | 429-400-7 | 199327-61-2 | Repr. Cat. 2; R61 R52-53 | T R: 61-52/53 S: 53-45-61 | |
612-254-00-5 | reaction products of diisopropanolamine with formaldehyde (1:4) | | 432-440-8 | 220444-73-5 | Carc. Cat. 3; R40 Xn; R22 C; R34 R43 N; R51-53 | C; N R: 22-34-40-43-51/53 S: (1/2-)13-25-26-36/37/39-45-61 | |
612-255-00-0 | 1-(3-methoxypropyl)-4-piperidinamine | | 431-950-8 | 179474-79-4 | Xn; R21/22 C; R34 R52-53 | C R: 21/22-34-52/53 S: (1/2-)26-36/37/39-45-61 | |
612-256-00-6 | benzyl(S)-2-[(2′-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate | | 427-470-3 | 137864-22-3 | Xn; R22 R43 | Xn R: 22-43 S: (2-)36/37 | |
612-257-00-1 | tripropylammonium dihydrogenphosphate | | 433-700-3 | 35687-90-2 | Xn; R22 | Xn R: 22 S: (2-)22 | |
612-259-00-2 | N-ethyl-3-trimethoxysilyl-2-methyl-propanamine | | 437-720-3 | 227085-51-0 | Xi; R41 | Xi R: 41 S: (2-)26-39 | |
612-261-00-3 | 3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline | | 441-190-9 | 121451-05-6 | Xn; R22 R43 N; R50-53 | Xn; N R: 22-43-50/53 S: (2-)24-37-60-61 | C ≥ 25 %: Xn, N; R22-43-50/53 2,5 % ≤ C < 25 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
612-265-00-5 | bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate | | 444-360-0 | 191617-13-7 | R52-53 | R: 52/53 S: 61 | |
612-266-00-0 | 3-chloro-4-(3-fluorobenzyloxy)aniline | | 445-590-4 | 202197-26-0 | Muta. Cat. 3; R68 Xn; R22-48/22 N; R50-53 | Xn; N R: 22-48/22-68-50/53 S: (2-)22-36/37-60-61 | |
612-267-00-6 | bis(hydrogenated tallow C 16-18-alkyl)hydroxylamine | | 418-370-0 | — | R43 R53 | Xi R: 43-53 S: (2-)36/37-61 | |
612-269-00-7 | mixture of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole; 1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole; mixture of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline; N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline | | 420-720-2 | — | R53 | R: 53 S: 22-61 | |
612-270-00-2 | (S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride | | 433-010-2 | — | Xn; R22 R43 R52-53 | Xn R: 22-43-52/53 S: (2-)22-36/37-61 | |
612-271-00-8 | mixture of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate; ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate | | 434-970-5 | 160987-57-5 | R53 | R: 53 S: 61 | |
612-272-00-3 | ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate | | 435-210-5 | — | N; R51-53 | N R: 51/53 S: 61 | |
612-273-00-9 | alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride | | 435-650-8 | — | Xn; R22 C; R35 N; R50-53 | C; N R: 22-35-50/53 S: (1/2-)26-36/37/39-45-60-61 | |
612-274-00-4 | (R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate | | 445-750-3 | — | Xn; R22 Xi; R41 R43 R52-53 | Xn R: 22-41-43-52/53 S: (2-)22-24-26-37/39-61 | |
612-275-00-X | fatty acids, C 18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil | | 447-880-6 | 206565-89-1 | Xi; R38-41 R43 N; R50-53 | Xi; N R: 38-41-43-50/53 S: (2-)23-26-36/37/39-60-61 | C ≥ 20 %: Xi, N; R38-41-43-50/53 10 % ≤ C < 20 %: Xi, N; R41-43-50/53 5 % ≤ C < 10 %: Xi, N; R36-43-50/53 2,5 % ≤ C < 5 %: Xi, N; R43-50/53 1 % ≤ C < 2,5 %: Xi, N; R43-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
612-276-00-5 | 1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts | | 451-430-4 | 500717-36-2 | Xi; R41 R43 R52-53 | Xi R: 41-43-52/53 S: (2-)22-24-26-36/37/39-61 | |
612-277-00-0 | mixture of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium; 4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium | | 451-440-9 | 586372-44-3 | Xi; R41 | Xi R: 41 S: (2-)22-26-39 | |
612-278-00-6 | ethidium bromide; 3,8-diamino-1-ethyl-6-phenylphenantridinium bromide | | 214-984-6 | 1239-45-8 | Muta. Cat. 3; R68 T+; R26 Xn; R22 | T+ R: 22-26-68 S: (1/2-)28-36/37-45-63 | |
612-279-00-1 | (R,S)-2-amino-3,3-dimethylbutane amide | | 447-860-7 | 144177-62-8 | Repr. Cat. 3; R62 Xn; R48/22 Xi; R36/38 R43 | Xn R: 36/38-43-48/22-62 S: (2-)22-26-36/37 | |
612-280-00-7 | 3-amino-9-ethyl carbazole; 9-ethylcarbazol-3-ylamine | H | 205-057-7 | 132-32-1 | Carc. Cat. 2; R45 | T R: 45 S: 53-45 | |
613-116-01-4 | tolylfluanid (ISO); dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide; [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | | 211-986-9 | 731-27-1 | Xi; R36/37/38 R43 N; R50 | Xi; N R: 36/37/38-43-50 S: (2-)25-36/37-46-61 | C ≥ 20 %: Xi, N; R36/37/38-43-50 2,5 % ≤ C < 20 %: Xi, N; R43-50 1 % ≤ C < 2,5 %: Xi; R43 |
613-280-00-X | tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one; dimethyl propyleneurea | | 230-625-6 | 7226-23-5 | Repr. Cat. 3; R62 Xn; R22 Xi; R41 | Xn R: 22-41-62 S: 26-36/37/39 | |
613-281-00-5 | quinoline | E | 202-051-6 | 91-22-5 | Carc. Cat. 2; R45 Muta. Cat. 3; R68 Xn; R21/22 Xi; R36/38 N; R51-53 | T; N R: 45-21/22-36/38-68-51/53 S: 53-45-61 | |
613-282-00-0 | triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol | | — | 131983-72-7 | N; R51-53 | N R: 51/53 S: 61 | |
613-283-00-6 | ketoconazole; 1-[4-[4-[[(2 SR,4 RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone | E | 265-667-4 | 65277-42-1 | Repr. Cat. 2; R60 T; R25 Xn; R48/22 N; R50-53 | T; N R: 60-25-48/22-50/53 S: 53-45-60-61 | |
613-284-00-1 | metconazole (ISO); (1 RS,5 RS;1 RS,5 SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol | | — | 125116-23-6 | Repr. Cat. 3; R63 Xn; R22 N; R51-53 | Xn; N R: 22-63-51/53 S: (2-)36/37-46-61 | |
613-285-00-7 | 1-hydroxybenzotriazole, anhydrous; [1] 1-hydroxybenzotriazole, monohydrated [2] | | 219-989-7 [1] 219-989-7 [2] | 2592-95-2 [1] 123333-53-9 [2] | E; R2 | E R: 2 S: 16-35 | |
613-286-00-2 | potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)] | | 418-260-2 | 183196-57-8 | R43 | Xi R: 43 S: (2-)24-37 | |
613-286-01-X | potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate; [containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)] | | 418-260-2 | 183196-57-8 | Repr. Cat. 2; R61 R43 | T R: 61-43 S: 53-45 | |
613-287-00-8 | 1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole | | 419-540-7 | 160194-26-3 | Xn; R22 R43 N; R51-53 | Xn; N R: 22-43-51/53 S: (2-)24-37-61 | |
613-288-00-3 | 1,3-bis(dimethylcarbamoyl)-imidazolium chloride | | 420-930-4 | 135756-61-5 | Xn; R22 Xi; R41 R52-53 | Xn R: 22-41-52/53 S: (2-)22-26-37/39-61 | |
613-289-00-9 | 3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole | | 432-020-4 | 142623-48-1 | N; R50-53 | N R: 50/53 S: 60-61 | |
613-290-00-4 | 4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride | | 432-470-1 | 189012-93-9 | Xi; R41 R43 N; R50-53 | Xi; N R: 41-43-50/53 S: (2-)24-26-37/39-60-61 | |
613-291-00-X | 2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one | | 434-820-9 | 106461-41-0 | Xn; R48/22 N; R50-53 | Xn; N R: 48/22-50/53 S: (2-)22-36-60-61 | |
613-292-00-5 | N,N′,N″-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine | | 435-010-8 | 26157-73-3 | Muta. Cat. 3; R68 R52-53 | Xn R: 68-52/53 S: (2-)36/37-61 | |
613-293-00-0 | 2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester | | 448-050-6 | 444065-11-6 | R53 | R: 53 S: 61 | |
613-294-00-6 | 2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester | | 448-260-8 | 379268-96-9 | R53 | R: 53 S: 61 | |
613-295-00-1 | 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride | | 448-720-8 | 363138-44-7 | Xn; R22 Xi; R41 R52-53 | Xn R: 22-41-52/53 S: (2-)22-26-39-61 | |
613-296-00-7 | pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate | | 418-270-7 | — | R43 R52-53 | Xi R: 43-52/53 S: (2-)24-37-47-61 | |
613-297-00-2 | 5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole | | 420-820-6 | — | R10 Xn; R22 N; R51-53 | Xn; N R: 10-22-51/53 S: (2-)16-61 | |
613-298-00-8 | bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate | | 421-560-6 | — | Xn; R48/22 Xi; R41 N; R51-53 | Xn; N R: 41-48/22-51/53 S: (2-)22-26-36/39-61 | |
613-299-00-3 | main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt; main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt | | 422-610-1 | — | Xi; R41 | Xi R: 41 S: (2-)22-26-39 | |
613-300-00-7 | 1-imidazol-1-yl-octadecan-2-ol | | 434-120-3 | — | R43 R53 | Xi R: 43-53 S: (2-)24-37-61 | |
613-301-00-2 | dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate | | 443-910-7 | — | R53 | R: 53 S: 61 | |
613-302-00-8 | disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate | | 432-980-4 | 243858-60-8 | Xi; R41 | Xi R: 41 S: (2-)22-26-39 | |
613-303-00-3 | 2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine | | 429-800-1 | 95737-68-1 | N; R50-53 | N R: 50/53 S: 60-61 | |
613-304-00-9 | 5,6-dihydroxy-2,3-dihydro-1H-indolium bromide | | 421-170-6 | 138937-28-7 | Xn; R22 Xi; R41 | Xn R: 22-41 S: (2-)22-26-39 | |
613-305-00-4 | 2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole | | 448-630-9 | 3147-77-1 | R53 | R: 53 S: 61 | |
613-306-00-X | (2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate | | 433-520-5 | 82911-69-1 | Xn; R22 R43 N; R51-53 | Xn; N R: 22-43-51/53 S: (2-)24-37-61 | |
613-307-00-5 | clothianidin (ISO); 3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine | | — | 210880-92-5 | Xn; R22 N; R50-53 | Xn; N R: 22-50/53 S: (2-)46-60-61 | C ≥ 25 %: Xn, N; R22-50/53 2,5 % ≤ C < 25 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52/53 |
613-308-00-0 | 2-amino-5-methylthiazole | | 423-800-5 | 7305-71-7 | Xn; R22-48/22 N; R50-53 | Xn; N R: 22-48/22-50/53 S: (2-)22-36-60-61 | |
613-309-00-6 | 1-methyl-3-phenyl-1-piperazine | | 431-180-2 | 5271-27-2 | Xn; R21/22 Xi; R38-41 R52-53 | Xn R: 21/22-38-41-52/53 S: (2-)26-36/37/39-61 | |
613-310-00-1 | (-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride | | 432-360-3 | 105813-13-6 | Xn; R22 R43 N; R50-53 | Xn; N R: 22-43-50/53 S: (2-)22-24-37-60-61 | |
613-311-00-7 | methyl-5-nitrophenyl-guanidine | | 435-500-1 | 152460-07-6 | Xn; R22 Xi; R36 R43 R52-53 | Xn R: 22-36-43-52/53 S: (2-)22-24-26-37-61 | |
613-312-00-2 | 2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride | | 420-200-5 | — | Xn; R22 Xi; R41 R43 R52-53 | Xn R: 22-41-43-52/53 S: (2-)22-26-36/37/39-61 | |
613-313-00-8 | 2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione | | 442-780-9 | 173838-67-0 | R52-53 | R: 52/53 S: 61 | |
613-314-00-3 | 4-decyloxazolidin-2-one; 4-decyl-1,3-oxazolidin-2-one | | 443-770-7 | 7693-82-5 | N; R50-53 | N R: 50/53 S: 22-24-60-61 | |
613-315-00-9 | tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate | | 430-390-1 | — | Xn; R20 R52-53 | Xn R: 20-52/53 S: (2-)25-61 | |
613-316-00-4 | trimethylopropane tri(3-aziridinylpropanoate); (TAZ) | H | 257-765-0 | 52234-82-9 | Muta. Cat. 3; R68 Xi; R41 R43 | Xn R: 41-43-68 S: 26-36/37/39-42 | |
615-044-00-1 | 4-chlorophenylisocyanate | | 203-176-9 | 104-12-1 | T+; R26 Xn; R22 Xi; R37/38-41 R42 N; R50-53 | T+; N R: 22-26-37/38-41-42-50/53 S: (1/2-)26-28-36/37/39-45-63-60-61 | |
615-045-00-7 | 4,4′-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate) | | 420-530-1 | — | R42/43 R53 | Xn R: 42/43-53 S: (2-)23-24-37-45-61 | |
616-126-00-X | 1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide | | 423-960-6 | 139756-01-7 | Xn; R22-48/22 R52-53 | Xn R: 22-48/22-52/53 S: (2-)22-36/37-61 | |
616-164-00-7 | dimoxystrobin (ISO); (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide | | — | 149961-52-4 | Carc. Cat. 3; R40 Repr. Cat. 3; R63 Xn; R20 N; R50-53 | Xn; N R: 20-40-63-50/53 S: (2-)36/37-46-60-61 | C ≥ 25 %: Xn, N; R20-40-63-50/53 5 % ≤ C < 25 %: Xn, N; R40-63-50/53 2,5 % ≤ C < 5 %: Xn, N; R40-50/53 1 % ≤ C < 2,5 %: Xn, N; R40-51/53 0,25 % ≤ C < 1 %: N; R51/53 0,025 % ≤ C < 0,25 %: R52-53 |
616-165-00-2 | beflubutamid (ISO); (RS)-N-benzyl-2-(α,α,α,4-tetrafluoro-m-tolyoxy)butyramide | | — | 113614-08-7 | N; R50-53 | N R: 50/53 S: 60-61 | C ≥ 0,25 %: N; R50/53 0,025 % ≤ C < 0,25 %: N; R51/53 0,0025 % ≤ C < 0,025 %: R52/53 |
616-166-00-8 | cyazofamid (ISO); 4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide | | — | 120116-88-3 | N; R50-53 | N R: 50/53 S: 60-61 | C ≥ 2,5 %: N; R50/53 0,25 % ≤ C < 2,5 %: N; R51-53 0,025 % ≤ C < 0,25 %: R52/53 |
616-167-00-3 | N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide | | 418-290-6 | 168612-06-4 | Xi; R36 R43 | Xi R: 36-43 S: (2-)24-26-37 | |
616-168-00-9 | 1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium | | 418-440-0 | 136997-71-2 | R43 | Xi R: 43 S: (2-)22-24-37 | |
616-169-00-4 | 4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one | | 420-220-4 | 92771-56-7 | R43 R53 | Xi R: 43-53 S: (2-)24-37-61 | |
616-170-00-X | (2R)-2-amino-2-phenylacetamide | | 420-370-0 | 6485-67-2 | Xi; R36 R43 | Xi R: 36-43 S: (2-)22-26-36/37 | |
616-171-00-5 | 2-(para-chlorophenyl)glycineamide | | 420-830-0 | 102333-75-5 | Xi; R41 R43 | Xi R: 41-43 S: (2-)24-26-37/39 | |
616-172-00-0 | N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide; (4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl | | 423-840-3 | 14691-89-5 | Xn; R22 | Xn R: 22 S: (2-)22 | |
616-174-00-1 | 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride | | 424-560-4 | 151257-01-1 | Xn; R22 Xi; R36 | Xn R: 22-36 S: (2-)22-26 | |
616-175-00-7 | 2-(2-hexyldecyloxy)benzamide | | 431-230-3 | 202483-62-3 | R53 | R: 53 S: 61 | |
616-176-00-2 | 3-N,N-bis(methoxyethyl)aminoacetanilide | | 432-530-7 | 24294-01-7 | Xn; R22 R52-53 | Xn R: 22-52/53 S: (2-)22-24-61 | |
616-177-00-8 | (3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide; N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide | | 432-970-1 | 217324-98-6 | R53 | R: 53 S: 61 | |
616-178-00-3 | N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide | | 434-500-9 | 52583-35-4 | R53 | R: 53 S: 22-61 | |
616-179-00-9 | 2-chloro-N-(4-methylphenyl)acetamide | | 435-170-9 | 16634-82-5 | Xi; R41 R43 N; R50-53 | Xi; N R: 41-43-50/53 S: (2-)22-26-36/37/39-60-61 | |
616-180-00-4 | N,N-(dimethylamino)thioacetamide hydrochloride | | 435-470-1 | 27366-72-9 | Repr. Cat. 2; R61 N; R50-53 | T; N R: 61-50/53 S: 53-45-60-61 | |
616-181-00-X | 4′-methyldodecane-1-sulfonanilide | | 435-490-9 | 17417-32-2 | N; R50-53 | N R: 50/53 S: 60-61 | |
616-182-00-5 | N′-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide | | 435-860-1 | 214417-91-1 | R43 N; R51-53 | Xi; N R: 43-51/53 S: (2-)24-37-61 | |
616-183-00-0 | N-dodecyl-4-methoxybenzamide | | 442-340-6 | 1854-15-5 | R53 | R: 53 S: 61 | |
616-184-00-6 | 3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide | | 442-560-2 | 105043-55-8 | R53 | R: 53 S: 61 | |
616-186-00-7 | N,N′-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide) | | 443-010-4 | 53641-10-4 | R52-53 | R: 52/53 S: 61 | |
616-188-00-8 | 2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide | | 443-980-9 | 221215-20-9 | R43 R53 | Xi R: 43-53 S: (2-)24-37-61 | |
616-189-00-3 | N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide | | 444-780-4 | 452962-97-9 | R53 | R: 53 S: 61 | |
616-190-00-9 | N-decyl-4-nitrobenzamide | | 445-880-0 | 64026-19-3 | R53 | R: 53 S: 61 | |
616-191-00-4 | 2-ethyl-N-methyl-N-(3-methylphenyl)butanamide | | 446-190-2 | 406488-30-0 | Xn; R22 Xi; R36/38 R43 N; R51-53 | Xn; N R: 22-36/38-43-51/53 S: (2-)24-26-37-61 | |
616-192-00-X | 2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilide | | 448-060-0 | 727678-39-9 | R53 | R: 53 S: 61 | |
616-193-00-5 | N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide | | 449-940-7 | 368450-39-9 | R53 | R: 53 S: 61 | |
616-194-00-0 | 2,2-diethoxy-N,N-dimethylacetamide | | 449-950-1 | 34640-92-1 | Xi; R36 | Xi R: 36 S: (2-)26 | |
616-196-00-1 | disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide | | 419-990-4 | — | N; R50-53 | N R: 50/53 S: 60-61 | |
616-197-00-7 | mixture of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate; N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide | | 422-500-1 | — | Xn; R48/22 | Xn R: 48/22 S: (2-)22-36 | |
616-198-00-2 | 1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene | | 423-300-7 | — | R43 R53 | Xi R: 43-53 S: (2-)24-37-61 | |
616-200-00-1 | mixture of: N,N′-ethane-1,2-diylbis(hexanamide); 12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide; N,N′-ethane-1,2-diylbis(12-hydroxyoctadecanamide) | | 432-430-3 | — | R43 R53 | Xi R: 43-53 S: (2-)24-37-61 | |
616-201-00-7 | 12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine | | 432-840-2 | 220926-97-6 | Xn; R20 R53 | Xn R: 20-53 S: (2-)22-61 | |
616-202-00-2 | mixture of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide; 2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide; 2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide | | 434-330-5 | — | Carc. Cat. 3; R40 R43 R53 | Xn R: 40-43-53 S: (2-)36/37-61 | |
616-203-00-8 | mixture of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide; N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide | | 442-280-0 | — | R53 | R: 53 S: 61 | |
616-204-00-3 | N,N″-(methylenedi-4,1-phenylene)bis[N′-octylurea] | | 451-060-3 | 122886-55-9 | R53 | R: 53 S: 61 | |
617-022-00-7 | mixture of: 1,2-dimethylpropylidene dihydroperoxide; dimethyl 1,2-benzenedicarboxylate | | 442-480-8 | — | O; R7 Xn; R22 C; R34 R43 N; R51-53 | O; C; N R: 7-22-34-43-51/53 S: (1/2-)3/7-14-26-36/37/39-45-50-61 | |
647-017-00-5 | laccase | | 420-150-4 | 80498-15-3 | R42 | Xn R: 42 S: (2-)23-45 | |
ANNEX 1C
The entries in Annex I with the following Index numbers are deleted:
024-004-01-4, 603-037-01-3, 603-155-00-8, and 611-084-00-9.